rfhg_169183.1

Basic information about the TSS

---

TSS ID: rfhg_169183.1 Species: human Chr: chr14		Start: 91114668 End: 91114700 Strand: +
Source datasets	FANTOM5|DRA000914
Protocol	CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2750858,EH38E1735951)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000523894.5:0 ENST00000522322.5:0 ENST00000523771.5:0 BX248060:0 BC010614:0 AY358516:0 GeneID: 80017 HGNC/MGI_ID: HGNC:20498 UniProt_ID: A0A0C4DGD8 Q7Z3D6 Nearer transcript ids and distances: NM_001102367.2:-33 ENST00000517362.5:-219 ENST00000428926.6:-226 AK022564:-226 AK091394:-229 ENST00000517518.5:-267 BX248782:-267 ENST00000523816.5:-278 BC065558:-278 ENST00000519019.5:-280 ENST00000518649.5:-292 ENST00000518868.5:-298 AK123532:-298 AK023200:-453 view more...

Gene_name: D-glutamate cyclase Gene_symbol: DGLUCY Gene_synonyms: FLJ39975 Gene_source: HGNC:20498

TATA-Box annotation

---

Distance to TSS:	-16
Nearest PromoterID:	NM_001286471
Entrez ID:	80017
Nearest Unigene:	Hs.309849
Nearest Refseq:	NM_024952
Nearest Ensembl:	ENSG00000133943
Gene Name:	D-glutamate cyclase
Gene Alias:	C14orf159
Gene Type:	protein-coding
CpG%:	0.031250
GC%:	0.484848
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DGLUCY p2@DGLUCY p3@DGLUCY p4@DGLUCY p5@DGLUCY p6@DGLUCY p7@DGLUCY p8@DGLUCY p9@DGLUCY p10@DGLUCY
Sample		p1@DGLUCY	p2@DGLUCY	p3@DGLUCY	p4@DGLUCY	p5@DGLUCY	p6@DGLUCY	p7@DGLUCY	p8@DGLUCY	p9@DGLUCY	p10@DGLUCY
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	3.31	0.78	4.29	0.00	0.00	1.56	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	3.24	1.01	2.63	0.00	0.00	1.82	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	3.47	0.58	4.05	0.00	0.00	2.31	0.00	0.19	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1.66	0.21	4.57	0.00	0.21	2.91	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.25	0.90	4.95	0.00	0.22	2.25	0.00	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1.74	0.97	4.26	0.00	0.19	3.29	0.00	0.19	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.45	1.74	4.58	0.00	0.44	2.18	0.00	0.22	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3.63	1.45	4.60	0.00	0.00	2.66	0.00	0.48	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.06	2.35	3.85	0.21	0.43	3.63	0.00	0.64	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	8.11	2.32	5.80	0.00	0.58	9.85	0.00	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.26	2.83	7.28	0.00	0.00	7.28	0.00	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.16	2.44	7.32	0.00	0.81	6.10	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.90	7.41	1.13	1.61	0.16	0.16	0.16	1.13	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	14.43	7.22	0.60	1.20	0.15	0.00	0.00	0.75	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.86	10.32	0.66	1.10	0.00	0.22	0.00	0.88	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.06	6.29	1.76	0.50	0.25	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.17	7.64	0.87	0.66	0.00	0.22	0.22	0.66	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.28	5.91	0.84	0.84	0.42	0.00	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.60	6.40	1.60	2.67	0.00	0.00	0.00	2.67	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.83	8.12	1.20	1.65	0.15	0.00	0.15	0.45	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.96	8.02	0.94	0.67	0.27	0.00	0.13	1.07	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.36	8.63	0.86	0.35	0.00	0.00	0.17	0.35	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.21	7.63	0.39	0.65	0.13	0.13	0.13	0.65	0.39	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.46	9.71	0.73	0.49	0.24	0.00	0.00	0.49	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.03	7.48	0.26	1.81	0.52	0.00	0.26	0.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.86	9.18	0.63	0.95	0.00	0.00	0.00	0.63	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.34	9.34	1.10	0.00	0.00	0.55	0.00	2.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.73	5.89	0.94	1.41	0.24	0.00	0.71	1.89	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.05	5.33	1.13	0.65	0.00	0.00	0.48	0.65	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	8.14	8.69	1.45	0.54	0.00	0.00	0.18	1.45	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.26	6.07	0.63	1.26	0.00	0.00	0.00	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.60	7.23	0.59	1.17	0.20	0.00	0.39	0.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.65	6.54	0.42	1.27	0.21	0.00	0.42	0.63	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.08	9.57	0.66	1.32	0.33	0.16	0.33	0.82	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.28	6.36	1.31	0.75	0.00	0.00	0.19	0.75	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.62	4.60	0.38	1.15	0.00	0.00	0.19	0.96	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.36	6.95	0.61	0.82	0.00	0.00	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.86	6.45	0.60	1.81	0.20	0.40	1.01	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.83	6.21	0.54	0.81	0.27	0.00	1.62	0.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.16	9.36	0.24	1.92	0.72	0.00	0.48	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.18	5.41	0.47	1.18	0.24	0.24	1.18	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	6.44	5.71	1.02	1.02	0.15	0.00	1.32	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	11.18	5.69	0.21	0.84	0.21	0.00	1.69	0.63	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.39	7.52	1.05	1.75	0.35	0.17	1.22	0.35	0.87	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.03	8.43	0.40	1.41	0.00	0.00	1.20	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.77	7.44	0.23	1.63	0.00	0.00	2.33	0.47	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.64	6.00	0.00	2.40	0.72	0.00	1.20	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.52	8.35	0.00	1.49	0.30	0.00	0.89	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.77	5.74	0.48	1.44	0.00	0.00	0.72	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.27	5.26	1.01	1.21	0.20	0.00	1.01	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.84	7.38	0.20	1.43	0.00	0.00	2.25	1.23	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.12	5.78	0.44	1.11	0.00	0.00	1.33	0.22	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.74	6.03	0.35	1.42	0.00	0.00	0.35	0.71	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	4.64	4.31	0.66	0.33	0.99	0.00	0.33	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	12.58	0.00	1.68	0.00	0.00	1.68	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	3.67	11.94	0.00	0.00	0.46	0.00	0.46	1.38	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.75	4.54	0.00	2.92	0.00	0.00	1.30	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.31	3.53	0.00	1.93	0.00	0.00	0.00	0.64	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.86	10.69	0.63	2.20	0.31	0.00	2.83	0.63	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	5.64	4.23	0.71	2.12	0.71	0.00	1.41	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	4.49	5.05	0.00	2.24	0.00	0.00	2.80	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	6.37	1.59	3.18	0.00	0.00	5.57	0.80	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.15	8.83	0.68	3.06	0.34	0.00	4.76	1.36	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.77	4.55	0.32	2.92	0.00	0.00	2.60	0.97	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.03	3.90	0.00	3.19	0.00	0.00	1.77	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	15.79	0.00	15.79	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.31	2.93	0.49	1.46	0.00	0.00	0.00	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.45	2.48	0.00	1.49	0.00	0.00	3.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	5.16	0.47	2.81	0.47	0.00	2.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.91	2.65	0.00	5.30	0.33	0.00	6.62	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	9.59	3.09	0.31	3.40	0.00	0.00	4.64	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.64	2.14	0.00	3.67	0.31	0.00	1.83	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	9.50	0.95	0.00	0.16	0.16	0.00	0.00	0.16	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	16.84	0.96	0.00	0.00	1.12	0.00	0.16	0.00	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	11.58	0.64	0.00	0.38	0.51	0.00	0.00	0.00	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	6.73	5.23	0.00	0.00	0.75	0.00	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	20.10	0.67	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	5.74	1.28	0.00	0.00	0.00	0.00	0.00	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	1.10	0.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.58	0.00	0.45	0.45	1.81	0.00	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	19.46	0.70	0.35	0.52	0.52	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	30.51	2.93	0.98	0.59	1.76	0.00	0.98	0.59	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	20.33	4.63	1.03	1.03	1.03	0.51	0.00	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	31.78	4.74	1.12	2.79	2.23	0.00	0.84	0.28	0.28	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	35.27	4.11	1.18	2.35	1.18	0.00	0.00	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	37.32	3.38	1.05	0.48	3.38	0.40	0.40	0.32	0.08	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	41.96	3.87	0.97	1.61	4.84	0.65	1.94	1.94	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	39.99	2.13	3.73	0.53	1.60	0.53	0.53	1.07	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	40.06	0.56	0.56	1.11	1.11	0.00	0.00	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	41.17	0.83	1.25	0.42	1.66	0.00	0.00	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	39.68	3.27	0.75	1.00	3.27	0.25	0.75	0.25	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	38.94	1.64	0.98	1.31	2.95	0.33	0.98	0.33	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	28.92	1.22	0.30	0.30	0.91	0.30	0.00	0.61	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	6.19	3.54	0.22	0.00	0.00	0.00	0.00	0.66	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.23	6.45	0.00	0.00	0.36	0.00	0.00	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.51	3.24	0.00	0.18	0.18	0.00	0.18	0.54	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	11.71	0.00	0.00	3.35	0.00	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	9.66	2.67	0.41	0.21	0.41	0.21	0.00	0.21	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	17.74	3.78	1.14	0.34	0.46	0.23	0.00	0.46	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	24.49	1.71	1.47	0.24	0.49	0.24	0.00	0.24	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.49	0.90	0.45	0.00	0.00	0.00	0.00	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.51	1.30	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.18	0.90	0.00	0.00	0.90	0.00	0.30	0.30	0.60	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	5.06	0.00	0.00	0.00	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	1.98	0.00	0.00	0.00	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.52	0.65	0.32	0.00	0.65	0.00	0.00	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.31	1.46	0.00	0.49	0.00	0.49	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.97	0.59	0.59	0.00	0.59	0.00	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.16	1.13	1.13	0.00	0.38	0.00	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	2.18	0.00	0.00	2.18	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.10	0.82	0.16	0.00	0.82	0.00	0.16	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.33	0.75	0.30	0.15	0.30	0.00	0.00	0.15	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.04	2.14	0.54	0.00	0.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.88	1.13	0.19	0.00	0.19	0.00	0.00	0.38	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.41	0.80	0.00	0.00	0.80	0.00	0.00	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	0.00	0.00	0.00	1.95	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.47	0.83	0.66	0.17	0.33	0.17	0.00	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	5.32	0.51	0.17	0.17	0.69	0.00	0.00	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.34	1.94	0.49	0.49	0.49	0.49	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.83	1.90	0.00	0.00	0.38	0.00	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	0.00	0.00	0.00	0.00	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.91	1.28	0.21	0.21	0.43	0.00	0.00	0.43	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.45	0.52	0.52	0.00	0.52	0.00	0.00	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.91	1.41	0.94	0.00	1.41	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.11	0.96	0.32	0.32	0.32	0.00	0.32	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.85	0.71	0.00	0.00	0.71	0.00	0.00	0.71	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.68	1.17	0.00	0.00	0.58	0.00	0.00	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	5.42	0.90	0.00	0.30	0.60	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.61	1.02	0.51	0.00	0.00	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.15	1.27	0.00	0.00	0.25	0.00	0.00	0.25	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	0.00	0.00	0.86	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.29	0.64	0.21	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.28	0.58	0.58	0.29	0.00	0.00	0.00	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	3.78	0.00	0.00	0.00	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.44	0.51	0.00	0.34	0.17	0.17	0.00	0.17	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	0.00	0.00	2.11	0.00	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.43	0.64	0.21	0.00	0.43	0.00	0.21	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.81	1.20	0.00	0.00	0.60	0.00	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	1.46	0.00	0.00	0.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.06	1.38	0.23	0.00	0.23	0.00	0.00	0.23	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	2.55	0.00	0.00	0.00	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.84	1.03	0.62	0.41	0.00	0.00	0.00	0.21	0.00	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.90	1.53	0.00	0.31	0.61	0.00	0.00	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1.91	0.00	0.48	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.32	0.67	0.44	0.22	0.44	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	3.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.65	2.77	0.00	0.00	0.00	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.30	1.06	0.00	0.53	0.53	0.00	0.00	0.53	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	0.73	0.00	0.00	0.36	0.00	0.73	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.83	2.70	2.09	0.12	0.49	0.49	0.00	0.12	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	8.39	1.88	0.34	0.17	0.00	0.00	0.00	0.00	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.45	3.36	1.05	0.21	0.21	0.63	0.00	0.00	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	9.41	4.53	2.09	0.00	0.70	0.35	0.00	1.74	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	5.82	3.56	1.29	0.16	0.49	0.32	0.00	0.81	0.49	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	5.97	1.19	2.09	0.30	0.15	0.45	0.00	0.30	0.60	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	26.03	18.35	2.29	4.59	0.57	0.57	3.67	0.92	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	21.92	19.42	1.25	4.89	0.50	0.88	3.38	1.13	0.13	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	18.78	21.51	2.84	5.01	0.34	0.91	3.53	1.02	0.11	0.34
Basophils, donor1	12241-129G9	20.92	0.78	5.23	2.62	1.31	2.35	2.35	0.00	0.26	0.00
Basophils, donor2	12242-129H1	31.75	0.72	4.33	2.53	0.72	1.08	4.33	0.00	0.00	0.36
Basophils, donor3	12243-129H2	24.99	0.73	1.62	2.79	0.44	1.32	1.47	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	5.82	1.72	0.43	0.00	0.65	0.43	0.00	0.43	0.22	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	9.14	1.83	0.46	0.46	1.83	0.00	0.00	0.46	0.46	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	3.14	0.00	0.00	1.26	0.00	0.00	1.88	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	4.78	1.46	0.21	0.00	1.25	0.00	0.21	0.42	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	4.15	2.30	0.00	0.00	0.46	0.00	0.23	0.23	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	8.82	1.08	0.00	0.00	0.18	0.18	0.00	0.36	0.18	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	13.60	18.55	6.70	5.05	0.62	2.99	2.68	1.34	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	11.88	26.55	5.36	10.01	0.47	0.70	9.08	0.70	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	32.94	13.43	7.67	8.31	1.60	1.92	7.99	0.64	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	0.00	0.00	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	25.36	0.00	0.56	2.25	2.25	0.00	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	17.82	0.37	3.16	0.93	0.93	0.74	1.30	0.00	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	32.27	0.66	3.29	0.88	1.54	1.54	1.54	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	64.25	3.40	1.98	3.96	12.45	0.00	2.83	1.13	0.00	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	62.17	4.93	3.03	4.93	9.10	0.76	1.52	0.38	0.00	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.69	1.97	3.62	4.60	9.20	0.00	1.97	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	9.11	0.29	1.88	1.73	0.87	0.58	3.47	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	7.24	0.00	1.51	1.21	0.91	0.30	0.60	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	11.84	0.00	2.61	2.37	1.42	0.95	3.32	0.00	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.85	0.00	0.50	0.84	0.17	0.17	0.84	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.86	0.00	0.55	0.28	0.00	0.28	0.83	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	7.44	0.00	1.24	0.74	0.00	0.50	1.24	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.07	0.00	1.17	1.37	0.78	0.20	5.48	0.00	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	6.77	0.36	1.07	2.85	0.71	0.53	5.70	0.00	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	9.36	0.22	1.31	2.39	1.09	0.22	5.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.02	0.00	1.17	0.47	0.23	0.94	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	0.00	0.53	0.53	0.53	0.00	0.00	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	19.97	0.00	0.00	1.11	1.11	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.16	0.00	0.59	0.89	0.00	0.15	0.45	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.39	0.00	0.40	0.40	0.60	0.40	0.40	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.12	0.42	0.83	0.83	0.42	0.00	1.25	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.41	0.23	0.92	2.06	0.23	0.92	2.06	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.33	0.23	0.45	1.13	0.45	0.00	1.58	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	0.00	1.75	3.06	0.00	0.44	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.99	0.54	0.54	1.61	0.54	0.54	6.19	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.64	0.17	1.57	2.27	0.87	1.40	5.41	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.10	0.42	1.26	5.05	2.10	0.42	7.15	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.31	0.37	0.37	3.86	0.37	0.37	2.57	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.41	0.00	0.35	1.41	0.00	0.00	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.63	0.00	0.44	3.07	0.00	0.00	0.88	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.45	0.00	0.70	3.84	0.35	0.17	5.06	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.43	0.37	1.86	2.60	0.00	1.12	3.72	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.72	0.43	1.29	2.80	0.43	0.43	3.88	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.19	0.41	0.82	6.55	0.82	0.41	4.91	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.17	0.00	0.70	2.78	0.00	0.46	1.16	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.34	0.23	0.23	4.64	0.46	0.23	4.64	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	64.08	1.53	3.71	3.49	4.14	0.65	3.05	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	65.37	0.69	4.16	0.23	6.24	0.92	0.23	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	59.57	1.08	4.55	3.03	4.77	1.95	3.47	0.00	0.22	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	53.88	1.40	4.98	2.65	2.96	1.87	2.65	0.00	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	52.57	1.75	3.67	0.52	1.92	1.40	0.00	0.00	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	66.44	1.56	6.47	3.34	2.01	1.34	4.24	0.45	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	63.03	1.79	1.53	4.85	4.59	0.77	3.32	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	67.41	1.10	2.42	0.00	7.03	1.10	0.00	0.44	0.00	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	66.11	1.26	4.21	7.79	4.84	1.89	3.37	0.00	0.21	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	4.06	16.26	8.13	0.00	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	30.51	8.81	6.78	5.42	0.68	0.68	10.17	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	25.89	3.11	5.18	14.50	0.00	1.04	3.11	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	35.18	5.86	11.19	11.73	1.07	1.07	5.86	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.41	7.50	11.79	14.47	0.54	0.54	6.97	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	25.97	8.42	11.23	16.85	0.00	2.11	9.83	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	25.88	6.27	6.27	10.98	0.78	0.78	7.84	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	25.05	5.27	10.55	10.55	1.32	3.95	3.95	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	28.77	5.75	27.12	9.86	2.47	9.86	4.93	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	23.21	1.45	21.04	8.71	0.00	7.98	5.80	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	19.18	5.05	22.72	8.58	0.00	1.51	2.02	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	10.91	4.04	0.81	4.04	0.40	0.40	0.40	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.59	3.99	0.40	2.80	0.00	0.00	0.40	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	10.04	7.03	8.03	2.01	0.00	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	14.05	2.25	2.81	3.37	1.69	1.12	2.81	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	40.21	14.65	5.64	2.25	0.38	1.50	1.50	1.13	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	35.63	20.29	6.99	2.71	1.13	0.90	2.93	2.48	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	22.49	1.79	7.14	4.28	1.43	2.50	1.43	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	21.43	0.61	7.96	7.35	0.61	0.61	3.67	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	26.23	3.35	6.40	3.66	2.44	3.05	2.44	0.00	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	62.28	8.68	8.68	14.80	14.55	2.55	13.27	1.79	1.02	2.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	68.05	6.51	9.43	0.90	15.95	5.39	0.90	2.25	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	64.68	6.04	9.20	20.41	10.92	2.87	13.22	0.86	0.86	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	33.66	7.11	7.59	10.90	0.47	0.00	5.22	0.95	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	41.44	2.81	9.13	0.70	6.32	1.40	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	56.04	0.00	6.59	16.48	13.18	0.00	6.59	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	31.65	6.50	7.08	10.98	6.94	3.32	9.54	0.72	0.58	1.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	50.50	8.30	9.32	1.19	12.37	2.71	0.68	3.05	1.19	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	55.62	5.96	8.06	10.96	11.77	4.67	12.57	2.26	0.81	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	28.24	3.59	5.83	10.31	5.83	2.24	8.97	0.45	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	34.24	2.45	6.99	0.70	8.73	1.75	0.70	0.00	0.00	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	47.52	3.52	11.44	14.08	7.92	2.20	9.68	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	35.00	4.64	8.01	10.54	8.85	2.95	8.43	2.11	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	41.35	6.23	9.14	0.42	5.82	3.12	0.00	1.87	0.62	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	35.75	5.68	10.36	6.01	6.01	6.68	8.69	1.00	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	27.74	6.53	7.34	10.06	2.72	1.63	2.99	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	43.95	6.97	9.11	1.07	3.75	2.14	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	48.42	5.38	12.55	3.59	3.59	1.79	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	39.31	5.75	9.46	10.38	7.42	3.89	10.20	0.93	0.56	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.31	4.33	7.15	1.08	7.15	3.68	0.22	0.87	1.08	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	31.73	5.04	9.46	10.09	7.15	3.78	9.04	0.63	0.63	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	34.38	6.57	5.56	9.61	3.03	2.53	8.60	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	33.79	5.63	8.23	1.30	4.77	1.30	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	41.40	4.79	11.77	13.07	3.49	1.74	9.15	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.66	6.93	3.96	12.37	2.97	1.98	6.93	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	33.23	5.54	3.69	20.31	0.92	0.00	8.31	0.92	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	1.40	4.19	19.54	4.19	1.40	8.37	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	48.46	4.43	6.65	14.95	3.05	0.83	6.65	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	46.13	6.87	5.64	19.88	4.42	0.74	5.89	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	47.74	10.78	4.62	10.78	1.54	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	37.60	6.09	3.22	16.83	1.43	0.72	11.82	0.72	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	34.62	5.54	4.15	8.31	1.38	4.15	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	24.55	3.60	8.51	9.17	3.27	2.29	3.93	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	21.78	3.00	4.13	6.76	3.00	1.88	3.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	31.31	2.78	8.58	4.80	1.77	5.05	2.78	0.00	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.28	1.84	2.06	0.23	0.46	0.69	0.46	0.00	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1.92	0.48	1.20	0.24	0.00	0.48	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2.46	0.55	2.46	0.27	0.55	1.37	0.00	0.27	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.00	1.20	1.80	0.30	0.90	0.60	0.30	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.12	0.48	1.68	0.72	0.24	0.96	0.96	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	1.82	1.14	2.96	0.23	0.68	1.14	0.45	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.39	1.74	1.52	1.09	0.22	0.87	0.43	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.47	1.84	1.32	0.79	0.00	1.05	1.05	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.46	0.47	1.17	0.70	0.00	0.47	1.17	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.64	1.21	3.62	2.11	0.60	1.21	0.00	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.36	1.16	2.03	0.00	0.29	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	6.13	2.13	1.87	0.53	0.00	0.80	1.33	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.94	0.00	1.31	0.44	0.00	3.50	0.88	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	2.28	0.46	3.19	0.91	0.00	2.73	1.82	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1.49	0.00	3.73	2.24	0.00	5.22	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.16	0.72	2.52	0.00	0.00	0.72	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	3.16	0.29	1.44	0.29	0.00	0.29	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.36	0.94	1.89	0.71	0.00	0.47	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.17	1.90	0.00	1.58	0.32	0.63	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2.77	0.62	2.15	0.31	0.31	1.54	0.92	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.53	1.28	2.24	1.60	0.32	0.64	0.64	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.97	2.29	1.53	0.00	0.38	0.38	1.53	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.94	1.18	1.97	1.18	0.00	0.39	0.79	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	3.03	0.00	2.27	0.76	0.00	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	3.21	0.00	6.42	4.01	0.00	4.01	8.83	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	3.50	1.40	6.29	3.50	0.00	2.80	5.60	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	11.02	0.00	4.01	1.00	0.00	1.00	3.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	21.93	1.83	5.48	1.83	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	16.80	4.45	0.00	0.49	0.00	0.00	0.00	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	7.58	3.89	0.53	0.11	0.21	0.11	0.00	0.21	0.42	0.11
Chondrocyte - de diff, donor1	11261-116G1	15.95	1.39	0.35	1.04	1.73	0.00	0.69	0.35	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	11.73	1.42	1.07	1.07	3.55	0.00	0.00	0.71	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	10.01	0.91	0.23	0.80	1.25	0.11	0.11	0.11	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	18.80	0.90	0.00	0.90	0.90	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	15.37	0.81	0.00	1.62	1.21	0.40	0.00	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	12.16	10.44	1.26	0.80	0.11	0.11	0.23	1.61	1.26	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	9.62	3.21	0.43	0.21	0.00	0.00	0.00	1.50	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	6.55	5.22	0.44	0.09	0.18	0.09	0.18	0.71	0.18	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.06	15.41	6.79	3.39	3.85	1.65	1.65	2.75	1.56	0.46
Corneal Epithelial Cells, donor1	11526-119I5	8.78	4.83	0.44	0.88	0.88	0.44	0.00	0.88	0.66	0.66
Corneal Epithelial Cells, donor2	11606-120I4	6.83	6.83	2.28	0.00	1.14	0.00	0.00	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.90	3.58	0.26	0.26	1.53	0.26	0.00	0.51	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	43.92	2.64	0.33	2.48	1.98	0.00	1.16	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	43.84	5.36	0.95	1.89	1.58	0.32	2.21	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	10.35	0.00	0.00	0.00	0.00	13.80	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	38.66	3.56	0.43	1.08	2.70	0.11	1.30	0.00	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	21.18	4.78	2.39	0.34	0.68	0.00	0.68	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	16.97	3.26	0.65	1.31	0.65	0.00	0.65	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	19.84	2.90	1.94	0.97	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	6.34	4.50	0.50	0.33	0.83	0.33	0.00	1.00	0.67	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	12.32	5.87	0.59	0.00	0.59	0.00	0.00	1.17	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	9.62	7.35	1.70	0.28	0.85	0.85	0.28	1.41	1.41	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	4.72	1.18	0.00	1.57	1.57	0.39	1.97	1.57	1.18
Endothelial Cells - Artery, donor1	11264-116G4	7.56	2.62	1.45	0.00	1.75	0.87	0.00	1.45	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	8.47	3.76	1.65	0.00	0.47	0.71	0.00	1.18	1.41	0.47
Endothelial Cells - Artery, donor3	11413-118E9	12.10	4.73	1.05	0.00	1.40	0.35	0.00	1.05	0.53	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	13.08	12.86	1.33	1.55	1.77	0.00	1.33	0.22	0.66	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	18.86	8.82	2.43	2.13	1.52	0.61	0.91	2.13	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	15.22	10.99	3.10	1.69	1.69	0.56	0.00	1.97	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	6.54	3.86	2.97	0.59	0.00	0.00	0.00	1.49	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	0.52	0.52	0.00	0.00	0.00	0.00	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	5.53	3.40	0.85	0.71	0.99	0.28	0.00	1.13	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	16.40	6.00	2.00	0.00	2.40	0.00	0.80	1.20	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	7.86	3.67	1.57	0.52	1.57	1.05	0.52	2.10	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	15.41	13.92	2.48	0.99	1.24	1.12	0.99	4.60	1.74	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.21	8.04	1.74	1.30	1.96	0.65	1.09	1.74	0.22	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	16.73	8.30	1.71	1.10	0.61	0.61	0.24	1.59	0.37	0.24
Endothelial Cells - Vein, donor1	11267-116G7	9.10	4.55	1.14	0.00	2.28	0.00	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.08	7.68	0.00	0.00	0.00	0.00	0.00	2.10	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	9.11	5.18	1.73	0.63	2.04	0.16	0.31	1.41	0.94	0.79
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	6.60	0.00	3.30	3.30	1.65	0.00	28.05	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	3.57	3.57	0.00	0.00	0.00	17.83	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.38	2.69	0.00	0.49	1.71	0.24	0.00	0.73	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	7.39	3.28	0.00	1.64	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.43	0.99	0.00	0.11	0.55	0.00	0.00	0.00	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.16	1.63	0.22	0.11	0.43	0.00	0.00	0.22	0.22	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	8.37	1.09	0.49	0.00	0.49	0.00	0.12	0.36	0.12	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.80	5.32	0.27	1.64	3.82	0.41	0.27	1.23	1.36	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.50	2.64	0.21	0.11	0.95	0.11	0.21	0.63	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	41.37	8.17	2.63	0.00	4.74	0.26	0.26	1.32	2.11	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.96	1.66	0.33	0.33	1.00	0.00	0.00	1.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	9.07	3.63	0.45	0.00	0.45	0.00	0.00	0.91	0.91	0.45
Fibroblast - Cardiac, donor2	11345-117G4	4.55	0.00	2.27	0.00	0.00	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.20	1.89	0.63	0.16	0.47	0.00	0.00	0.47	0.63	0.00
Fibroblast - Cardiac, donor4	11452-119A3	20.01	4.85	0.30	0.61	0.91	0.30	0.00	0.91	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	14.47	4.44	0.13	0.13	1.40	0.13	0.00	0.25	0.25	0.38
Fibroblast - Cardiac, donor6	11460-119B2	11.52	5.00	0.15	0.00	1.67	0.30	0.00	1.21	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.97	1.61	0.40	0.00	0.00	0.13	0.13	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	1.73	0.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	1.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.53	0.69	0.23	0.23	0.23	0.00	0.23	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	22.56	2.71	1.36	1.19	1.70	0.34	0.00	0.17	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	15.97	2.11	0.23	0.47	1.17	0.00	0.00	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	15.57	1.42	0.47	0.47	0.47	0.00	0.00	0.94	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	13.78	1.45	0.24	0.36	0.60	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	12.43	2.26	0.23	0.23	0.11	0.23	0.00	0.23	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	11.86	2.62	0.00	0.17	1.05	0.35	0.00	0.17	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	10.23	4.06	0.49	0.65	0.32	0.32	0.00	0.16	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	16.24	3.12	0.00	0.42	0.62	0.00	0.21	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.41	3.41	0.00	0.52	0.52	0.00	0.79	0.52	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	10.81	2.77	0.53	0.13	0.92	0.13	0.13	0.26	0.00	0.26
Fibroblast - Gingival, donor3	11394-118C8	23.49	1.35	0.00	1.26	0.58	0.19	0.39	0.39	0.00	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	25.97	4.16	0.00	3.12	1.04	0.00	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.28	0.53	0.35	1.59	0.00	0.00	0.00	0.00	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	16.21	2.81	0.16	0.62	0.62	0.00	0.16	0.31	0.00	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	12.98	1.89	0.27	0.27	0.41	0.14	0.00	0.41	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.41	1.06	0.35	0.35	0.35	0.35	0.71	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	15.65	1.32	0.29	0.73	0.58	0.15	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	14.32	1.64	0.55	0.41	0.55	0.14	0.41	0.55	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	6.80	1.21	0.22	0.00	0.88	0.00	0.11	0.11	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.11	1.61	0.88	1.17	0.15	0.00	0.59	0.15	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	13.59	4.08	1.36	0.00	0.00	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	2.98	0.00	0.00	2.98	0.00	1.49	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	15.41	4.01	0.63	0.00	1.06	0.00	0.00	0.42	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	25.82	4.17	1.67	1.67	0.83	1.67	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	5.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.92	2.52	0.84	1.40	0.28	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	13.40	3.25	0.41	0.41	1.22	0.00	0.41	0.81	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	8.53	2.72	0.58	0.39	0.58	0.19	0.00	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.83	1.52	0.61	0.30	1.21	0.30	0.00	0.15	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	10.71	1.84	0.00	0.31	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	13.36	0.38	0.00	0.00	0.76	0.00	0.00	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.18	1.35	0.00	0.00	0.00	0.00	0.27	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.22	0.12	0.12	1.51	0.70	0.12	0.35	0.00	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.86	2.65	0.22	0.00	0.22	0.33	0.00	0.66	1.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.61	5.89	0.81	0.41	0.20	0.20	0.41	1.02	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	17.37	3.34	0.67	0.67	1.34	0.00	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	12.65	1.19	0.00	0.00	0.40	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	14.69	4.56	1.19	0.99	1.39	0.40	0.20	0.40	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.72	0.18	0.18	1.07	0.36	0.00	0.36	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.99	0.20	0.20	0.39	0.39	0.20	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.95	6.02	0.90	0.90	1.50	0.60	0.30	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.55	1.73	0.11	0.86	0.22	0.22	0.00	0.32	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	22.02	3.29	1.01	1.27	0.76	0.00	0.00	0.25	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	13.13	0.82	0.16	1.31	0.16	0.00	0.00	0.16	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	22.26	8.02	0.20	1.20	1.40	0.00	0.00	0.80	0.60	0.40
Fibroblast - skin normal, donor2	11561-120D4	7.53	1.81	0.00	0.00	0.20	0.00	0.10	0.00	0.00	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.09	9.67	0.60	1.81	0.91	0.00	0.30	0.60	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.28	0.75	0.41	1.41	0.25	0.00	0.08	0.08	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	19.66	0.85	0.51	2.56	0.85	0.17	0.68	0.00	0.00	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.36	4.27	0.66	0.66	2.30	0.33	0.00	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	8.10	1.60	0.11	0.11	0.32	0.00	0.11	0.11	0.11	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	7.76	1.69	0.17	0.17	0.51	0.34	0.00	0.00	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.12	1.41	0.31	0.78	0.31	0.00	0.16	0.31	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	42.71	1.74	2.61	0.87	8.72	0.00	0.87	3.49	0.87	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1.91	1.73	0.35	0.17	0.17	0.17	0.00	0.17	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	3.64	1.30	0.78	0.00	1.04	0.00	0.00	0.78	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	4.34	1.28	1.28	0.26	0.26	0.00	0.00	0.51	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	1.53	3.83	0.77	0.00	0.00	0.00	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	7.66	6.38	1.91	0.64	0.00	0.64	0.00	1.91	2.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	7.42	7.99	5.42	0.86	0.00	0.57	0.29	3.42	1.71	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.41	15.72	9.38	1.10	0.00	0.55	0.55	3.31	3.58	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	10.27	5.71	13.24	0.68	0.00	3.20	0.00	1.83	2.74	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	9.11	6.34	5.94	0.79	0.20	3.17	0.00	0.59	1.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.16	11.90	9.78	0.79	0.26	1.59	0.26	3.70	5.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	10.11	3.91	14.68	0.00	0.33	5.22	0.00	0.98	5.22	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4.42	8.84	1.77	0.44	0.00	1.33	0.44	0.88	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	4.24	6.50	1.84	0.57	0.00	0.85	0.42	1.70	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	4.93	5.17	1.97	0.49	0.12	0.99	0.25	0.49	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	3.49	6.72	1.61	0.00	0.00	0.81	0.27	0.54	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	3.72	3.35	0.87	0.12	0.12	1.24	0.00	0.50	1.24	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	3.60	5.81	1.38	0.14	0.00	0.83	0.42	0.97	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	4.07	5.49	0.81	0.41	0.00	0.00	0.20	0.81	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	7.07	6.39	3.65	0.00	0.00	0.68	0.23	0.46	1.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	4.24	6.48	0.87	0.12	0.25	0.25	0.50	1.00	0.87	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	6.34	5.46	1.09	0.44	0.00	0.22	0.22	0.44	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	6.50	5.02	2.66	0.30	0.00	0.89	0.00	0.89	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	7.15	7.63	1.27	0.79	0.00	0.64	0.48	0.79	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	4.47	8.04	2.68	0.45	0.00	1.12	0.22	0.89	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	5.44	2.62	2.42	0.00	0.20	1.41	0.00	1.21	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	5.26	5.26	2.04	0.00	0.17	0.34	0.00	0.34	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	5.85	6.47	1.86	0.35	0.18	1.42	0.18	0.89	1.68	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5.31	4.16	3.43	0.00	0.10	1.98	0.00	0.62	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	6.83	2.56	5.12	0.17	0.34	1.54	0.00	0.17	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	6.64	3.87	2.99	0.44	0.22	1.55	0.00	0.66	0.77	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	5.91	4.91	2.75	0.67	0.25	1.66	0.67	1.25	1.16	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	7.35	1.84	2.25	0.41	0.41	1.23	0.20	0.61	1.84	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	6.81	3.92	3.09	0.00	0.21	1.44	0.00	0.62	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	6.92	2.54	2.88	0.23	0.12	1.04	0.00	0.69	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	5.00	3.34	2.50	0.50	0.50	0.83	0.33	0.83	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	6.61	2.65	1.54	0.66	0.00	0.66	0.00	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	6.15	2.95	3.32	0.49	0.49	1.11	0.37	0.49	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.43	4.21	2.92	0.81	0.32	0.97	0.00	1.30	1.62	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.62	1.92	1.92	0.00	0.32	1.60	0.32	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	3.51	2.08	2.08	0.00	0.19	0.76	0.09	0.47	0.38	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	3.01	2.21	2.37	0.16	0.63	0.95	0.32	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	5.78	4.26	3.04	0.00	0.61	1.22	0.00	0.30	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	3.76	2.40	2.51	0.21	0.31	1.67	0.00	0.21	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	4.83	3.07	4.17	0.00	0.66	0.66	0.44	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	4.49	3.37	3.09	0.28	0.00	0.28	0.28	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	2.78	2.31	2.31	0.00	0.19	0.74	0.09	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	3.74	2.67	2.67	0.00	0.00	2.14	0.27	1.07	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	2.60	1.53	1.84	0.00	0.92	0.46	0.00	0.77	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4.02	1.55	2.20	0.13	0.52	0.78	0.00	0.52	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	1.63	1.90	3.25	0.00	0.27	1.36	0.00	1.08	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	3.13	0.92	2.03	0.18	0.18	0.74	0.00	0.55	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	6.36	1.10	2.41	0.00	0.22	1.32	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	6.94	0.99	14.88	0.00	0.99	0.99	0.00	0.00	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	6.86	1.71	1.58	0.13	0.13	0.53	0.00	0.26	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	8.27	1.21	0.81	1.01	0.40	0.81	0.00	0.40	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	7.37	2.80	10.17	0.51	0.25	4.57	0.00	1.02	2.03	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	5.97	11.94	1.00	0.60	0.60	1.39	0.60	0.80	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	6.47	5.70	3.24	0.77	0.15	0.62	0.31	1.39	1.85	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.91	10.02	2.86	0.82	0.00	1.64	0.41	2.05	1.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	2.82	5.63	2.82	0.00	0.00	0.63	0.00	0.94	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.26	3.11	2.54	0.00	0.00	0.85	0.00	0.57	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	5.07	8.76	0.00	0.46	0.00	0.92	0.46	0.92	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	0.00	0.00	0.00	0.00	2.47	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	5.03	8.90	1.55	0.00	0.39	0.77	0.39	1.16	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	6.42	1.60	0.00	0.00	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	5.22	3.48	0.00	0.00	0.00	1.74	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.21	4.88	2.28	0.33	0.00	0.65	0.33	2.28	1.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	6.18	5.77	2.06	0.82	0.00	1.24	0.00	1.24	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	10.00	13.33	0.00	0.00	3.33	0.00	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	5.87	4.75	2.24	0.28	0.00	0.28	0.28	0.56	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4.90	3.60	2.61	0.00	0.33	0.98	0.33	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.03	11.74	7.55	0.00	0.00	1.68	0.84	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	4.13	7.63	2.86	0.00	0.00	0.64	0.32	1.27	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	3.40	5.43	2.04	0.00	0.34	0.68	0.00	1.36	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	8.35	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	8.59	10.31	5.15	0.00	0.57	0.00	0.00	1.15	2.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	4.44	4.44	2.66	0.00	0.00	1.48	0.00	0.59	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1.69	5.08	3.39	0.00	0.00	3.39	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	4.56	5.80	4.14	0.00	0.00	2.90	0.41	0.41	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	7.59	6.67	2.99	0.00	0.23	2.30	0.23	1.38	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	5.27	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	6.15	4.23	0.77	0.00	0.00	1.15	0.00	0.00	1.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	5.22	3.26	4.24	0.00	0.33	1.63	0.33	1.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	2.68	4.68	4.68	0.00	0.67	0.67	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	4.62	4.24	4.24	0.00	0.00	2.31	0.00	1.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	5.48	2.40	5.82	0.00	0.34	2.05	0.00	0.68	1.37	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	7.45	2.48	4.97	0.00	0.00	4.97	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.44	8.02	7.55	0.00	0.47	1.42	0.00	1.42	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	9.05	6.64	5.43	0.00	0.00	2.41	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	12.72	5.60	8.14	0.51	0.00	3.56	0.00	0.51	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	7.58	6.38	5.98	0.40	0.80	1.20	0.00	1.60	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	10.85	2.47	7.40	0.00	1.48	0.99	0.00	1.97	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	7.08	4.72	4.72	0.00	0.00	1.18	0.00	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	6.42	5.25	7.58	0.00	0.00	1.17	0.00	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	8.34	3.95	5.27	0.44	0.44	1.76	0.44	0.88	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	11.02	1.70	6.78	0.00	0.85	0.85	0.00	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	12.54	3.58	7.16	0.00	0.00	2.39	0.60	1.79	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	8.25	4.37	3.40	0.00	0.49	0.00	0.49	0.49	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	7.99	1.14	0.00	1.14	0.00	2.28	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.90	2.08	0.00	0.42	0.83	0.00	0.42	1.25	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	3.37	0.00	0.00	0.00	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	14.59	0.32	0.00	0.63	0.63	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	1.25	0.00	0.42	0.42	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	0.00	0.00	0.12	0.00	0.00	0.70	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	0.00	0.00	0.46	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	0.00	0.00	0.11	0.00	0.00	0.33	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	0.00	0.00	0.43	0.00	0.00	0.43	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	0.00	0.00	0.12	0.00	0.00	0.37	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	0.00	0.00	0.51	0.00	0.00	0.51	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.00	0.00	0.32	0.00	0.00	0.32	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.18	13.99	1.68	1.68	3.36	0.56	0.00	0.56	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.52	3.46	0.87	0.00	2.16	0.00	0.00	0.43	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	7.93	0.00	0.00	0.00	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	14.11	6.00	1.06	0.35	0.71	0.00	0.00	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	17.44	2.91	1.45	0.73	2.91	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.34	2.27	0.17	0.00	0.00	0.00	0.00	0.35	0.17	0.17
Hepatocyte, donor1	11523-119I2	29.05	2.42	1.21	0.00	2.42	1.21	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	15.08	0.00	4.31	1.08	0.00	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	34.36	0.61	1.23	3.07	1.84	0.61	0.61	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	13.05	16.32	1.96	2.61	0.00	0.65	0.65	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	9.79	8.91	0.52	3.32	0.00	0.17	2.27	1.40	1.22	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.67	3.02	0.96	0.41	0.14	0.00	0.55	0.41	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	9.55	0.00	3.18	3.18	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	20.03	0.00	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	11.08	5.54	0.00	0.00	2.77	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	10.01	2.50	0.00	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	15.38	2.56	0.00	0.00	5.13	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	18.28	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	11.37	3.25	0.00	0.00	1.62	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	11.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	14.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	15.88	3.97	1.32	0.00	0.00	1.32	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	6.65	1.11	2.22	0.00	1.11	1.11	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	2.52	10.71	0.63	1.26	0.00	0.00	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	10.83	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.81	9.69	0.65	0.65	0.00	0.65	0.65	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	9.66	1.61	0.00	0.00	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	11.95	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	14.67	13.85	4.07	0.81	0.00	0.00	2.44	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.46	8.40	1.26	0.00	0.00	0.42	0.42	1.26	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	14.37	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	5.63	11.25	0.80	0.00	0.80	0.00	0.80	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	4.62	1.85	0.92	0.00	0.00	0.00	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.30	3.78	0.47	0.47	0.47	0.00	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	4.53	0.00	0.00	0.00	0.91	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	10.76	5.38	3.23	0.00	0.00	1.08	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	5.08	2.54	0.00	0.00	0.00	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	9.57	1.28	0.64	0.64	0.64	0.00	3.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	14.58	1.82	0.00	0.00	1.82	0.00	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.00	8.57	2.14	1.43	0.00	0.00	0.00	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	13.27	0.00	0.00	3.32	0.00	0.00	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.01	7.72	0.93	0.00	0.31	1.23	0.62	0.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	7.02	3.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	6.29	6.29	0.00	3.14	0.00	0.00	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.82	14.60	2.09	0.70	0.00	1.39	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	11.07	4.43	2.21	0.00	0.00	0.00	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	9.73	6.48	0.00	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	14.82	6.98	1.74	0.00	0.87	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	2.25	0.00	0.00	0.00	4.50	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	17.42	0.00	0.00	0.00	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	5.33	13.87	2.13	3.20	1.07	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	15.24	0.00	1.39	0.00	0.00	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	14.25	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	14.73	1.84	0.92	0.00	0.00	1.84	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	6.05	3.03	0.00	0.00	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	18.63	12.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	10.57	4.23	2.11	0.00	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	3.43	2.37	0.98	0.16	0.98	0.33	0.16	0.41	0.65	0.41
Keratinocyte - epidermal, donor2	11349-117G8	4.10	1.76	0.00	0.00	0.59	0.00	0.00	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	5.49	2.75	0.38	0.19	0.76	0.09	0.00	1.04	0.38	0.47
Keratinocyte - oral, donor1	11251-116E9	13.74	5.68	0.68	0.23	1.25	0.23	0.11	2.16	0.45	0.45
Keratocytes, donor1	11527-119I6	9.63	0.69	0.00	1.38	0.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	19.92	1.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	13.63	0.79	0.00	0.59	0.20	0.00	0.00	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	2.16	3.24	0.00	0.00	0.00	1.08	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	9.46	13.61	2.08	3.23	0.00	0.23	1.27	2.88	1.73	0.12
Lens Epithelial Cells, donor3	11690-122I7	7.57	1.82	1.01	0.20	0.20	0.00	0.00	0.10	0.00	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.82	4.86	2.49	1.66	2.37	0.71	1.42	1.30	1.07	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.84	4.47	0.28	1.95	0.56	0.00	1.40	1.12	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	17.00	3.15	1.89	1.89	1.26	0.79	2.05	0.47	1.42	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	3.23	1.08	0.54	1.61	0.00	0.00	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.29	4.10	0.63	1.26	1.89	0.00	0.00	0.63	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.94	4.31	1.29	0.54	2.26	0.43	0.97	1.94	0.75	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	12.72	2.46	1.64	0.82	2.46	0.00	0.41	1.64	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.39	2.78	1.26	1.01	1.77	0.25	0.00	1.01	0.51	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.08	3.80	1.55	1.27	1.83	0.56	0.42	0.42	0.56	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.31	1.58	0.79	1.19	0.79	0.00	0.79	0.40	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	10.66	2.71	0.39	0.78	2.33	0.58	0.39	0.78	0.58	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	15.92	3.15	1.48	0.74	1.48	0.37	0.74	0.56	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.54	3.48	1.39	1.05	2.44	0.00	0.70	0.70	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.69	4.77	1.19	0.72	0.95	0.24	0.00	0.48	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	14.28	1.37	1.65	0.55	1.24	0.55	1.51	1.10	0.69	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.39	2.77	1.85	0.62	1.23	0.31	0.62	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.60	3.43	0.62	0.62	0.62	0.62	0.62	0.31	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.95	3.84	1.46	1.65	2.38	0.55	0.73	0.37	0.55	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.85	3.29	1.65	1.97	1.97	0.33	1.65	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.96	2.34	0.88	0.88	1.76	0.29	0.88	0.59	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.67	3.49	1.49	1.00	2.99	1.00	1.74	1.74	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.18	2.42	1.94	1.94	1.94	0.48	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	10.77	2.69	1.35	0.81	1.62	0.54	0.54	1.35	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.44	3.78	1.51	0.00	3.03	0.61	0.91	0.91	1.06	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.85	2.59	2.07	0.00	2.07	0.00	0.52	1.04	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.42	2.93	0.42	0.42	1.05	0.21	0.00	0.63	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	16.54	2.11	1.20	1.20	1.80	0.75	0.45	0.45	1.05	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.76	4.13	1.38	1.38	2.06	0.00	0.00	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.84	2.82	0.75	1.13	0.75	0.19	0.19	0.19	0.38	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.10	2.44	2.12	0.85	2.23	0.21	1.06	0.85	0.42	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.66	3.88	1.94	0.00	1.94	0.48	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.58	1.65	0.33	0.66	0.33	0.33	0.66	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	15.11	2.48	1.36	0.50	2.97	0.74	0.99	0.99	0.37	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.85	3.70	1.11	0.74	1.48	0.74	1.11	1.11	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.13	2.22	0.25	0.00	0.99	0.00	0.00	0.74	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.44	2.61	1.51	0.27	1.51	0.55	0.00	0.82	1.10	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.68	2.89	2.89	0.96	1.29	1.29	0.64	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.83	2.74	2.13	0.61	0.61	0.30	0.00	1.22	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.04	3.50	1.40	1.12	3.22	0.28	0.84	0.84	0.70	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.38	4.98	2.84	1.42	1.07	0.36	1.78	1.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.09	4.36	0.48	0.00	0.97	0.00	0.00	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.14	2.18	1.24	1.09	2.02	0.78	0.93	0.62	0.78	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.74	1.79	1.43	0.36	1.07	0.00	0.36	0.36	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.11	1.63	0.00	1.31	1.31	0.00	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.48	2.83	0.47	1.18	1.88	0.47	0.71	0.94	0.71	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.88	2.60	1.86	0.62	1.86	1.36	1.24	1.24	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.22	1.54	0.77	0.51	1.28	0.77	0.00	0.77	0.00	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.32	3.88	1.19	0.90	1.19	0.60	0.60	0.60	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.00	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	0.00	1.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.00	0.00	2.54	0.00	0.00	0.85	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	0.00	0.00	0.00	0.00	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.00	1.87	0.00	0.00	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	0.00	0.52	0.00	0.00	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.00	0.00	0.68	0.00	0.00	0.68	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.00	0.29	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.00	0.00	1.80	0.00	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.00	0.00	1.90	0.00	0.00	0.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.00	0.00	1.03	0.00	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.00	0.00	1.76	0.00	0.00	0.35	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	0.00	1.33	0.00	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.00	0.51	2.55	0.00	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.00	0.00	1.60	0.00	0.00	0.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.00	0.00	0.76	0.00	0.00	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.00	0.00	1.23	0.00	0.00	1.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.00	0.00	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.00	0.00	0.83	0.00	0.00	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.00	0.00	1.96	0.00	0.00	0.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	0.00	2.06	0.00	0.00	2.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.00	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.00	0.00	1.49	0.00	0.00	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.00	0.00	2.21	0.00	0.00	1.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.00	0.00	2.12	0.00	0.00	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	0.00	1.11	0.00	0.00	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	0.00	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.00	0.00	2.30	0.00	0.00	0.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	0.00	1.70	0.00	0.00	1.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.00	0.00	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.00	0.00	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	0.00	1.49	0.00	0.00	0.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.00	0.00	1.11	0.00	0.00	1.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.00	0.00	2.15	0.00	0.00	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.00	2.57	0.00	0.00	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.00	0.00	1.33	0.00	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.00	0.00	1.21	0.00	0.00	1.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.00	0.00	1.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.00	0.00	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	0.00	1.61	0.00	0.00	1.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	0.00	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	0.00	0.00	0.74	0.00	0.00	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	0.00	1.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	0.00	2.12	0.00	0.00	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.00	0.00	0.80	0.00	0.00	0.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.00	0.00	0.73	0.00	0.00	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.00	0.00	2.30	0.00	0.00	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.00	0.00	3.95	0.00	0.00	0.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	0.00	2.82	0.00	0.00	1.88	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.00	0.00	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.00	0.00	1.35	0.00	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	0.00	2.67	0.00	0.00	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.00	0.00	1.96	0.00	0.00	0.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.00	0.00	3.30	0.00	0.00	1.98	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.00	0.00	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	0.00	2.63	0.00	0.00	0.88	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.00	0.00	1.12	0.00	0.00	0.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.00	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.00	0.00	1.16	0.00	0.00	0.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	0.00	0.00	2.03	0.00	0.00	1.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.00	0.00	1.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.00	0.00	0.80	0.00	0.00	0.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	0.00	0.61	0.00	0.00	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.00	0.00	0.00	0.00	0.00	1.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.00	0.00	0.76	0.00	0.00	0.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.00	0.00	1.03	0.00	0.00	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	0.00	0.60	0.00	0.00	1.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.00	0.00	0.95	0.00	0.00	0.95	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.00	0.00	1.60	0.00	0.00	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	0.00	0.00	1.72	0.00	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	0.00	0.00	0.51	0.00	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.00	0.00	1.41	0.00	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	0.00	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	0.00	0.00	2.08	0.00	0.00	1.25	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.00	0.00	3.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.00	0.00	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.00	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.00	0.00	0.81	0.00	0.00	0.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	0.00	0.89	0.00	0.00	1.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.00	0.00	0.57	0.00	0.00	1.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	0.00	2.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.00	0.00	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.00	0.00	0.78	0.26	0.00	1.04	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	43.99	2.96	1.60	1.60	5.70	0.46	0.91	0.23	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	30.10	4.95	0.55	0.73	3.85	0.37	0.92	0.37	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	44.83	3.80	0.92	1.44	4.06	0.13	0.26	0.39	0.26	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	1.59	0.00	0.00	0.53	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	2.85	3.17	0.32	0.16	1.11	0.00	0.00	0.48	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	3.34	4.59	0.28	0.00	0.69	0.00	0.00	0.97	0.83	0.14
Mammary Epithelial Cell, donor1	11273-116H4	7.27	1.79	1.40	0.10	1.49	0.40	0.00	0.30	0.30	0.80
Mammary Epithelial Cell, donor2	11350-117G9	9.84	1.74	0.87	0.29	0.87	1.16	0.00	0.29	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	6.24	2.00	1.00	0.50	1.50	0.00	0.00	0.25	1.00	0.00
Mast cell - stimulated, donor1	11487-119E2	7.46	0.00	4.07	1.36	4.07	0.68	0.00	0.00	0.00	0.68
Mast cell, donor1	11563-120D6	40.88	1.51	12.54	4.76	5.73	4.11	1.30	0.54	0.11	0.87
Mast cell, donor2	11565-120D8	38.63	0.89	7.43	0.59	2.08	4.46	0.89	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	56.96	2.03	18.91	2.25	3.83	6.53	0.23	0.23	0.00	0.23
Mast cell, donor4	11567-120E1	40.60	2.66	13.12	1.06	1.42	3.55	0.53	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	49.13	4.77	14.08	2.77	5.77	6.76	1.55	0.44	0.22	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	21.01	2.92	5.84	0.58	2.92	1.75	0.00	0.00	0.00	2.33
Mast cell, expanded, donor5	11939-126A4	47.84	2.41	11.59	2.98	6.65	5.28	1.84	0.57	0.46	0.80
Mast cell, expanded, donor8	11941-126A6	36.65	2.85	10.38	1.17	3.51	4.02	0.17	0.17	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	17.51	1.99	1.29	0.30	2.69	0.40	0.00	0.90	0.30	0.40
Melanocyte - dark, donor2	11582-120F7	11.42	3.81	1.04	1.38	0.35	0.00	0.00	1.38	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	1.45	0.29	2.03	0.00	0.00	0.58	0.00	0.00	0.00	0.00
Melanocyte - light, donor1	11274-116H5	4.70	0.71	2.35	0.24	1.18	1.88	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	0.68	0.68	2.73	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	4.34	0.00	0.87	0.00	0.00	2.60	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	0.42	0.10	0.42	0.00	0.00	0.83	0.00	0.00	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	3.23	0.54	1.88	0.00	0.54	0.27	0.00	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	0.00	0.00	1.87	0.00	0.00	1.61	0.00	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	5.09	1.36	0.74	0.00	0.00	0.12	0.00	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	2.64	0.44	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	1.79	0.49	0.24	0.00	0.08	0.16	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	6.56	3.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.33	0.60	0.70	0.10	0.50	0.00	0.00	0.00	0.00	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	14.46	1.31	0.00	0.00	0.00	0.00	0.00	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	0.00	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.76	2.87	0.00	0.00	0.72	0.00	0.00	0.00	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.19	3.39	0.00	0.21	0.42	0.21	0.21	0.64	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.54	2.01	0.00	0.00	1.01	0.50	0.00	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.65	1.32	0.00	1.32	0.22	0.00	0.22	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.19	2.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.37	1.84	0.20	0.00	0.20	0.00	0.41	0.20	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	14.27	1.25	0.00	0.97	0.69	0.00	0.14	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.38	1.86	0.00	0.37	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	10.66	0.79	0.79	0.79	0.53	0.00	0.13	0.13	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.42	1.19	0.59	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.89	5.76	0.00	0.00	0.64	0.00	0.00	1.92	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.41	1.77	0.00	0.00	1.06	0.00	0.00	0.35	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.51	3.44	0.00	0.31	0.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.26	0.00	0.00	0.73	1.45	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	15.38	6.63	0.53	0.53	1.86	0.00	0.27	1.33	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	8.01	1.50	0.50	0.00	0.50	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	9.25	3.47	0.65	0.14	0.43	0.07	0.00	0.36	0.29	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	45.91	5.40	1.35	2.70	6.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	50.49	7.39	0.74	0.25	4.68	0.25	0.49	0.99	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	50.65	6.48	0.00	1.18	5.01	0.29	0.29	0.88	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	35.02	4.03	1.24	0.31	3.41	0.00	0.31	0.62	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	32.15	7.88	0.62	0.21	3.32	0.21	0.62	1.04	0.21	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	37.79	8.01	0.00	0.50	4.75	0.25	0.50	0.25	0.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	55.39	5.59	1.86	2.33	3.26	0.00	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	36.78	5.49	0.20	0.20	2.64	0.20	0.20	1.22	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	31.28	3.17	0.79	0.40	2.77	0.79	0.40	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	3.54	0.00	0.00	4.42	0.88	0.00	0.88	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	41.41	8.36	0.38	0.76	3.04	0.38	1.14	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	1.32	0.00	2.63	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.14	4.67	0.00	1.06	4.03	0.21	0.00	1.06	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	4.60	0.00	0.00	0.00	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.25	3.28	0.89	0.60	2.38	0.30	0.60	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	1.68	0.00	3.35	1.68	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	25.34	2.51	0.50	1.00	2.51	0.00	0.25	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	25.19	5.94	0.48	0.24	3.80	0.00	1.43	0.48	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.69	1.66	0.55	0.55	1.66	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.10	3.68	0.00	0.00	3.45	0.00	0.69	0.69	0.23	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	30.50	4.84	0.00	1.68	3.58	0.00	1.26	0.63	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.94	3.26	0.20	0.82	2.45	0.00	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	24.67	2.57	0.43	0.64	3.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.12	4.22	0.22	1.11	2.00	0.00	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.21	3.50	0.66	0.44	2.19	0.00	0.88	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.74	2.03	0.00	0.51	2.53	0.00	0.51	0.00	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.11	4.08	0.00	0.54	0.27	0.00	0.27	0.54	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	28.23	2.94	0.29	1.47	3.82	0.00	1.47	0.88	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	0.00	0.00	0.00	3.27	0.00	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.97	0.96	0.00	0.00	2.40	0.00	0.00	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	29.62	3.60	0.00	0.80	3.20	0.00	1.20	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	0.00	1.37	0.00	2.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.02	2.50	0.00	0.50	0.50	0.50	1.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	2.04	0.00	0.00	0.00	0.00	2.04	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.64	0.88	0.44	0.00	0.44	0.00	0.88	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	30.90	2.21	0.00	1.10	0.00	0.00	1.10	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.85	0.64	0.64	0.64	1.28	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.90	2.23	0.00	0.25	2.23	0.00	0.00	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	19.49	1.39	0.00	1.39	2.09	0.00	3.48	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	2.21	0.00	0.00	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	14.02	2.39	0.34	0.34	1.37	0.00	0.34	0.34	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	22.76	0.88	0.44	0.00	0.44	0.00	1.75	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.56	0.71	0.36	0.71	1.42	0.36	2.13	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	21.04	1.68	0.00	0.00	3.09	0.28	1.40	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.03	2.49	0.00	0.42	1.66	0.00	1.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.99	1.17	0.58	1.17	1.17	0.00	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.26	0.60	0.60	0.60	2.41	0.30	0.90	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.46	2.09	0.42	0.83	2.50	0.42	3.34	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	22.17	0.92	0.00	0.00	0.00	0.92	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	25.61	1.71	0.57	0.00	3.41	0.00	4.55	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.20	1.52	0.41	0.69	1.52	0.00	1.66	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	16.84	1.55	0.26	1.04	2.59	0.00	0.78	0.00	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.31	1.29	0.86	0.86	1.29	0.43	2.14	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	1.91	1.27	0.64	2.54	0.00	2.54	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.02	0.53	0.27	0.53	1.60	0.27	1.07	0.27	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	23.65	0.90	0.30	2.10	2.10	0.00	2.39	0.30	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.85	1.41	0.57	0.28	1.13	0.14	1.27	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.07	1.59	0.00	0.00	2.55	0.00	1.27	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.20	2.21	0.44	1.33	1.99	0.00	1.55	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.82	2.28	0.38	1.90	2.65	0.00	1.90	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	2.84	0.57	1.70	1.42	0.28	1.14	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	22.86	3.20	0.00	0.98	1.47	0.00	3.44	0.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	0.65	0.00	0.65	1.96	0.65	1.30	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.05	1.76	1.18	0.59	0.59	0.00	0.29	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	21.34	2.02	0.29	1.15	2.31	0.29	3.46	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	17.72	2.06	0.00	1.65	0.82	0.41	0.41	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.74	2.08	0.30	1.79	2.08	0.60	1.79	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	30.30	0.00	0.00	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	52.57	4.60	0.66	0.33	5.59	0.00	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	39.97	5.26	0.00	0.00	6.31	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	42.30	6.72	0.99	0.40	5.54	0.59	0.20	0.00	0.20	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.05	6.52	0.93	0.00	1.86	0.00	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	42.81	3.00	0.38	1.50	5.63	0.38	0.38	0.00	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	34.09	2.93	1.07	0.80	2.66	0.00	0.27	0.53	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	33.48	4.41	1.02	0.57	3.51	0.23	0.57	0.34	0.00	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	42.73	4.42	0.74	0.00	2.95	0.00	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	50.57	3.66	1.83	1.47	2.93	0.73	1.10	0.73	0.00	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	38.89	6.22	0.00	0.00	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.36	1.07	0.00	0.00	2.14	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	3.86	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	34.34	2.02	1.01	2.02	4.04	0.00	0.00	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	19.40	2.53	0.42	0.84	0.84	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	1.36	2.72	4.09	0.00	0.00	2.72	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.72	0.64	0.00	5.09	1.27	0.00	3.18	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	18.63	0.81	0.81	15.39	2.43	0.00	4.86	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	3.02	0.00	4.53	0.00	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	5.71	0.00	34.26	22.84	0.00	28.55	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	71.77	9.79	3.26	39.15	16.31	0.00	19.57	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	0.00	4.75	38.02	0.00	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	12.55	0.00	0.00	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	6.03	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.77	1.05	0.52	0.00	0.52	0.00	0.00	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.02	3.34	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.69	2.50	0.83	0.00	0.00	0.00	0.00	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	17.30	7.04	0.95	0.19	1.52	0.19	0.00	0.57	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	3.19	1.60	0.00	1.60	6.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	0.68	0.00	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	3.68	0.00	0.00	7.35	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.35	2.51	1.26	0.42	0.42	0.42	0.00	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	21.38	3.02	0.23	0.70	1.39	0.00	0.70	0.46	0.70	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	19.19	2.70	1.08	0.00	2.70	0.00	0.00	0.00	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.07	2.94	1.68	0.21	2.31	0.63	0.00	0.42	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	27.30	6.45	2.98	0.00	0.99	0.50	0.00	0.99	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	21.92	3.52	0.81	1.08	1.08	0.00	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	25.39	2.72	1.59	0.91	3.63	0.00	0.45	0.68	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.78	1.47	0.49	0.00	0.82	0.00	0.00	0.33	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.87	3.46	0.73	0.36	1.64	0.00	0.36	0.91	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.40	0.53	3.18	0.00	1.59	0.53	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	26.41	0.60	5.40	0.60	1.20	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.07	4.92	0.33	0.33	4.59	0.00	0.00	0.66	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.33	1.79	1.14	0.33	0.81	0.33	0.00	0.65	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.99	1.94	0.88	0.71	2.29	0.18	0.18	0.35	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	2.11	0.70	0.00	1.41	0.00	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.07	2.30	0.46	0.00	2.30	0.00	0.00	0.00	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.24	2.25	0.96	0.00	1.29	0.00	0.00	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	24.14	3.79	1.03	2.41	3.45	0.00	0.34	0.69	0.34	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.70	1.11	1.34	0.45	1.56	0.00	0.00	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.13	1.27	0.00	0.00	0.85	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	24.45	1.19	1.19	0.24	2.37	0.24	0.00	0.00	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	11.16	0.00	0.86	0.00	2.15	0.00	0.43	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.99	3.33	1.67	0.33	3.33	0.00	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.72	0.45	0.90	0.00	1.80	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	1.59	0.79	0.40	0.40	0.00	0.00	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	0.00	0.00	0.00	2.79	1.86	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	21.57	3.03	0.76	0.76	2.65	0.00	0.00	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.41	0.33	0.00	0.33	0.65	0.00	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.66	2.18	0.87	0.00	0.44	0.00	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.19	1.36	1.36	0.90	2.71	0.00	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	0.00	0.88	0.00	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	20.61	1.99	3.32	0.00	0.00	0.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	29.27	0.50	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.16	0.38	1.15	0.77	0.00	0.00	0.38	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	41.74	4.23	0.00	1.81	1.51	0.30	0.30	0.00	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.05	1.11	1.33	0.22	1.77	0.22	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	0.68	0.68	0.68	1.36	0.00	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	0.00	5.11	0.00	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	28.05	1.22	1.83	0.00	1.22	0.00	0.00	1.22	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.83	1.89	1.57	0.63	0.94	0.00	0.31	0.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.25	1.82	0.61	0.30	2.12	0.00	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	0.79	1.58	0.79	0.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	3.40	3.40	1.13	2.27	1.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.45	1.12	0.12	0.00	0.25	0.00	0.12	0.62	0.00	0.37
Myoblast, donor2	11322-117D8	20.71	3.64	0.38	0.77	1.53	0.19	0.19	0.19	0.19	0.19
Myoblast, donor3	11398-118D3	9.25	2.02	0.17	0.34	1.51	0.00	0.00	0.84	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	15.76	13.28	3.06	3.65	2.19	1.90	4.67	1.46	0.58	0.44
Natural Killer Cells, donor1	11230-116C6	26.14	1.54	8.30	4.92	2.46	3.08	4.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	17.79	1.21	7.84	5.13	2.11	3.02	3.02	0.60	0.00	0.60
Natural Killer Cells, donor3	11387-118C1	30.55	2.21	5.71	2.94	3.50	2.21	2.76	0.18	0.00	0.37
Neural stem cells, donor1	11275-116H6	11.98	2.54	4.36	0.00	0.73	1.81	0.00	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	9.63	3.85	5.78	1.93	0.00	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	4.55	1.14	3.41	0.00	0.00	0.00	0.00	1.14	0.00	0.00
Neurons, donor2	11574-120E8	8.59	0.66	0.44	0.00	0.22	0.44	0.00	0.22	0.00	0.00
Neurons, donor3	11655-122E8	6.58	0.00	0.82	0.00	0.82	0.82	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	1.86	0.93	0.93	2.78	1.86	1.86	13.92	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	2.90	0.00	0.00	8.70	14.49	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	1.22	7.94	7.94	0.61	1.83	45.81	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	14.49	1.42	0.83	0.00	0.47	0.24	0.00	0.24	0.00	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	18.88	0.98	1.30	0.00	0.33	0.65	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	12.23	2.81	0.00	0.20	0.60	0.20	0.20	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.29	0.41	1.10	0.41	0.55	0.00	0.00	0.00	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	14.04	1.16	1.01	1.01	0.29	0.00	0.14	0.43	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	12.49	0.57	0.23	0.34	0.57	0.00	0.00	0.11	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	13.05	1.07	0.29	0.88	0.10	0.10	0.29	0.39	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	9.03	4.21	0.00	0.00	0.60	0.00	0.00	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	10.00	0.21	0.00	0.00	0.43	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	10.29	1.14	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.97	0.00	0.00	1.24	0.00	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	7.23	1.17	0.20	0.00	0.39	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	2.81	0.70	0.70	0.00	0.00	0.00	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	7.46	0.89	0.53	0.18	0.00	0.00	0.00	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	16.76	3.54	0.17	0.59	1.68	0.00	0.00	0.59	0.25	0.51
Pericytes, donor1	11491-119E6	18.14	5.01	0.56	0.33	0.11	0.00	0.11	0.33	0.00	0.11
Pericytes, donor2	11571-120E5	9.73	2.72	0.00	0.00	0.23	0.00	0.00	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	4.68	2.03	0.00	0.20	0.20	0.00	0.00	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	7.46	1.24	0.23	0.79	0.11	0.00	0.11	0.11	0.00	0.00
Perineurial Cells, donor2	11579-120F4	12.42	6.35	0.55	0.55	0.83	0.28	0.09	0.55	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	43.35	2.87	8.29	4.14	3.19	1.91	1.59	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	28.65	2.20	6.37	4.16	1.22	0.98	5.39	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	31.32	2.07	3.49	4.27	1.68	1.55	2.46	0.00	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	3.35	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	5.54	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.14	1.18	1.18	0.00	0.20	0.00	0.00	0.00	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.48	0.95	0.00	0.00	0.32	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	6.75	0.94	0.38	0.19	0.56	0.00	0.00	0.00	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	12.92	3.65	0.26	0.13	0.39	0.00	0.13	0.26	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	7.20	2.03	0.00	0.00	0.45	0.00	0.00	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	12.47	1.49	0.00	0.32	0.32	0.00	0.00	0.00	0.21	0.00
Preadipocyte - omental, donor2	11329-117E6	13.97	0.44	0.00	0.00	0.00	0.00	0.44	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	7.31	1.00	0.29	0.43	0.14	0.00	0.00	0.00	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	18.70	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	8.60	2.76	0.00	0.31	0.61	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	12.04	2.83	0.18	0.18	1.06	0.00	0.00	0.18	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	10.73	1.87	0.00	0.17	0.51	0.00	0.00	0.34	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	13.41	5.22	0.19	0.09	1.02	0.09	0.19	0.65	0.28	0.28
Preadipocyte - visceral, donor2	11357-117H7	17.49	4.14	0.00	0.46	0.92	0.00	0.00	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	11.08	4.60	0.00	0.10	1.46	0.21	0.00	0.52	0.10	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	4.98	7.39	0.75	2.26	0.30	0.15	2.26	0.91	2.26	0.00
Prostate Epithelial Cells, donor2	11331-117E8	2.57	1.90	0.27	0.00	0.14	0.00	0.14	0.95	0.41	0.41
Prostate Epithelial Cells, donor3	11404-118D9	1.65	0.55	0.67	0.12	0.18	0.18	0.06	0.06	0.06	0.00
Prostate Stromal Cells, donor1	11254-116F3	8.43	2.05	0.34	1.03	0.46	0.00	0.11	0.00	0.34	0.00
Prostate Stromal Cells, donor2	11332-117E9	14.70	2.51	0.00	0.54	0.90	0.18	0.18	0.72	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	18.98	2.71	0.31	0.94	1.15	0.00	0.31	0.42	0.21	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.52	9.49	2.19	0.73	0.36	0.36	0.36	1.82	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	6.03	4.64	0.62	0.14	0.42	0.07	0.07	0.55	0.42	0.07
Renal Epithelial Cells, donor1	11517-119H5	11.67	6.09	1.52	0.51	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.09	7.82	0.71	0.71	0.00	0.71	0.00	0.71	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	6.88	4.76	1.38	0.42	0.00	0.21	0.11	0.64	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.06	7.49	0.68	0.68	2.04	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.21	8.89	1.21	0.13	1.48	0.27	0.27	0.81	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.77	7.33	1.55	0.00	0.89	0.22	0.00	0.67	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	4.66	6.65	0.67	0.00	0.67	0.00	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	12.77	8.80	0.88	0.66	1.54	0.00	0.22	1.76	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	14.42	11.91	0.00	0.63	0.00	0.00	0.00	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	11.37	8.60	2.22	1.39	0.00	0.28	0.55	0.55	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.08	7.52	1.88	0.54	0.27	0.27	0.27	0.81	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.70	5.06	1.27	0.42	0.00	0.00	0.84	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.86	6.75	0.96	0.19	0.39	0.39	0.19	1.16	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.74	11.93	1.30	1.30	0.00	0.52	0.52	1.81	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	16.49	12.51	2.27	0.85	0.28	0.28	0.28	1.99	0.85	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	11.32	6.17	0.00	0.00	0.00	1.03	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.78	5.02	1.76	0.25	0.25	0.25	0.00	0.00	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	27.40	4.94	3.61	4.54	1.20	2.00	1.60	0.13	0.40	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	23.23	1.79	1.79	1.79	0.89	1.79	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	18.71	2.20	4.95	1.65	3.30	0.55	0.00	0.55	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	20.88	2.90	0.58	2.90	2.32	0.00	1.16	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	8.06	1.30	0.52	1.56	0.26	0.39	0.39	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	6.65	1.59	0.70	0.30	0.40	0.50	0.20	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	9.48	2.12	1.00	0.67	0.45	0.56	0.11	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	6.33	1.12	0.37	0.62	0.12	0.12	0.12	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	6.99	1.05	0.23	0.58	0.35	0.00	0.23	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	8.78	2.08	0.46	0.92	0.69	0.00	0.23	0.46	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.94	0.96	1.51	1.23	0.27	0.27	0.14	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	6.96	1.06	0.91	0.15	0.30	0.30	0.15	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	9.50	0.72	0.90	0.72	0.36	0.72	0.36	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	9.18	1.58	1.15	0.72	0.29	1.00	0.43	0.14	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	6.55	0.64	1.07	0.32	0.32	0.21	0.11	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	8.41	1.99	1.11	0.89	0.66	0.00	0.44	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.93	1.72	0.76	0.76	0.19	0.19	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	7.17	2.14	0.56	1.21	0.09	0.28	0.09	0.09	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	10.90	1.69	1.69	1.50	0.19	0.75	0.56	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	6.24	1.99	0.93	0.80	0.13	1.19	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	6.72	0.78	1.07	0.88	0.00	0.58	0.10	0.29	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	7.64	1.34	1.53	0.38	0.19	0.38	0.76	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	7.16	0.43	0.85	0.53	0.32	0.64	0.00	0.00	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	5.61	0.84	0.84	0.56	0.28	0.56	0.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	7.69	1.71	1.20	0.85	0.85	1.37	0.17	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6.56	0.91	1.28	0.91	0.00	0.55	0.18	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.50	1.35	1.10	0.25	0.37	0.49	0.12	0.00	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	9.13	0.67	0.94	0.94	0.27	0.40	0.54	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.67	0.71	0.47	0.71	0.47	0.47	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.16	1.39	1.39	0.79	0.00	0.20	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	10.06	2.10	1.40	0.23	0.23	0.47	0.47	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	7.88	1.45	1.04	1.45	0.21	0.41	0.41	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.97	2.21	0.44	0.44	0.00	0.44	0.22	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	9.19	1.67	1.04	0.84	0.42	0.42	0.63	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	7.27	1.48	0.67	0.40	0.27	0.27	0.54	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	6.47	1.02	1.87	0.68	0.51	0.34	0.00	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	8.10	1.93	0.77	0.19	0.77	0.58	0.39	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	8.08	1.89	0.86	0.86	0.52	0.00	0.86	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	6.86	1.37	0.27	0.82	0.41	0.14	0.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.03	1.81	0.82	0.82	0.49	0.82	0.33	0.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.20	1.02	1.02	1.87	0.17	0.51	0.68	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	8.58	1.48	0.15	0.30	0.15	0.15	0.30	0.15	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	10.66	1.33	0.53	1.33	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	10.51	2.35	1.52	1.24	0.55	0.41	0.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	4.76	1.90	0.71	1.19	0.48	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	15.52	2.02	1.81	1.21	0.00	0.81	0.40	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	9.23	1.98	0.66	0.94	0.28	0.57	0.09	0.09	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	12.93	1.05	2.10	2.10	3.14	0.35	0.35	0.35	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.55	1.51	1.21	0.60	0.91	0.91	0.91	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	13.10	2.20	1.47	1.47	0.12	0.49	0.37	0.24	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	36.97	7.13	7.57	5.82	2.62	1.89	2.77	0.58	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	23.73	4.87	0.61	1.83	0.61	1.22	0.61	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.04	0.60	0.60	2.11	0.30	0.60	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.15	2.71	1.58	5.20	1.36	1.13	1.13	0.45	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	21.87	3.00	2.70	3.29	1.50	1.20	2.70	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	20.43	4.60	1.53	4.25	0.94	1.18	2.24	0.00	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.50	3.20	1.71	4.70	1.07	1.28	2.13	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	16.83	3.00	1.20	3.00	0.00	0.00	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	8.84	3.76	0.19	0.75	0.19	0.00	0.00	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	10.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	5.26	1.97	0.22	0.00	0.22	0.22	0.00	0.44	0.00	0.00
Sebocyte, donor1	11220-116B5	7.12	2.74	2.19	0.55	1.10	0.55	0.55	1.10	0.55	0.55
Sebocyte, donor2	11301-117B5	5.06	3.22	0.00	0.00	1.84	0.00	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	10.51	2.27	0.41	0.41	0.82	0.00	0.21	0.62	0.00	0.21
Sertoli Cells, donor1	11255-116F4	6.63	1.66	1.66	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	0.00	2.82	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.05	1.94	0.79	0.26	0.62	0.18	0.09	0.35	0.00	0.09
Skeletal Muscle Cells, donor2	11358-117H8	10.84	0.00	2.17	0.00	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	2.51	0.84	0.00	0.84	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	11.78	5.18	0.00	0.47	0.31	0.00	0.16	0.16	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	12.34	3.86	0.74	0.59	0.74	0.15	0.30	0.30	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	11.70	3.08	0.15	0.15	0.77	0.00	0.00	0.15	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.27	8.44	0.38	2.77	0.50	0.38	0.76	1.13	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	13.13	4.42	0.57	0.57	0.71	0.14	0.00	0.29	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	11.41	4.46	0.89	0.30	0.69	0.10	0.10	0.60	0.00	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.56	2.27	1.18	0.17	1.01	0.25	0.00	0.51	0.08	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	1.45	0.00	0.00	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.90	2.75	0.55	0.00	0.96	0.14	0.00	0.41	0.00	0.14
Skin - palm, donor1	10286-104F7	67.15	0.00	0.00	2.69	5.37	2.69	2.69	2.69	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.75	0.58	0.43	0.14	1.44	0.00	0.00	0.58	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	49.07	13.90	0.82	3.27	26.17	1.64	0.00	4.09	2.45	5.73
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.10	1.82	0.39	0.13	1.17	0.39	0.00	0.65	0.13	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	2.36	1.25	0.28	0.00	0.42	0.14	0.14	0.14	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	2.53	1.27	0.42	0.28	0.28	0.14	0.00	0.28	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	38.69	15.44	2.96	2.54	8.03	1.90	0.21	4.02	3.17	2.54
Small Airway Epithelial Cells, donor3	11406-118E2	2.32	1.12	0.45	0.22	0.52	0.45	0.07	0.30	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.79	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.90	2.45	0.67	0.22	1.78	0.00	0.22	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.23	0.59	0.00	0.00	0.59	0.00	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	9.06	0.44	0.00	0.66	1.55	0.00	0.22	0.66	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.48	2.36	0.79	0.00	0.39	0.00	0.00	0.79	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.95	1.55	0.00	0.00	0.77	0.00	0.00	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	2.00	2.00	0.00	1.00	1.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	4.52	2.13	0.13	0.00	0.40	0.00	0.00	0.40	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.53	0.22	0.00	0.22	1.11	0.00	0.22	0.00	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.76	0.51	0.13	0.64	0.77	0.26	0.00	0.13	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	5.21	1.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	11.22	1.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.68	1.85	0.00	0.28	1.00	0.00	0.00	0.43	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.97	3.25	0.33	0.16	0.65	0.00	0.00	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.57	0.00	0.61	0.00	0.30	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.86	0.76	0.00	0.76	0.51	0.00	0.00	0.00	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	0.00	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.34	0.48	0.95	0.00	0.00	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.88	3.98	0.15	0.00	0.44	0.00	0.00	0.44	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.85	3.44	0.22	0.43	1.29	0.22	0.00	0.22	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.39	3.57	0.21	0.10	0.52	0.00	0.00	0.63	0.10	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.97	1.86	0.15	0.15	0.62	0.15	0.00	0.62	0.46	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	1.08	0.00	0.00	1.08	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.17	2.39	0.00	0.00	0.60	0.00	0.00	0.90	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.56	2.39	0.00	0.34	0.00	0.00	0.00	0.00	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	11.15	3.85	0.24	0.55	0.24	0.00	0.08	0.55	0.08	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	13.89	1.51	1.51	0.30	2.42	0.50	0.00	0.40	0.40	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.29	2.73	0.00	2.05	1.14	0.00	1.37	0.91	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	0.60	0.00	0.00	1.21	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	11.13	3.18	0.00	0.26	0.53	0.00	0.00	0.53	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.05	2.13	0.13	1.46	0.13	0.13	0.13	0.00	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	12.40	3.76	0.13	1.25	0.88	0.25	0.25	0.38	0.00	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	20.55	2.28	0.25	0.76	0.76	0.00	0.25	0.25	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7.99	1.96	0.45	0.00	0.90	0.15	0.00	1.06	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	20.25	0.75	0.00	0.00	2.25	0.00	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	1.29	1.29	0.00	1.29	0.00	0.00	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	5.58	1.40	0.47	0.47	1.86	0.00	0.00	0.93	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.09	1.01	0.00	0.50	0.00	0.00	0.00	0.00	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	7.52	1.88	0.63	0.31	0.63	0.00	0.31	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.34	2.95	0.59	0.29	1.18	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	7.50	2.42	0.25	0.08	0.50	0.08	0.00	0.58	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.95	3.27	0.00	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.47	1.87	0.14	0.00	0.14	0.00	0.00	0.43	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.14	1.78	0.00	0.00	0.25	0.25	0.00	0.76	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.65	1.69	0.00	0.00	0.38	0.00	0.00	0.75	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	9.22	2.24	0.14	0.70	0.28	0.28	0.14	0.28	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	5.70	0.75	0.17	0.25	0.00	0.08	0.00	0.00	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.71	0.95	0.00	0.95	0.00	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.14	1.47	0.00	0.00	0.24	0.00	0.00	0.00	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	11.93	2.43	0.22	0.00	0.22	0.00	0.00	0.00	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.53	2.93	0.88	0.29	1.46	0.00	0.29	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.21	2.33	0.78	0.19	2.53	0.78	0.00	0.39	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.84	2.12	0.00	0.00	0.26	0.26	0.00	0.53	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	29.76	1.86	0.37	0.74	7.44	0.37	0.37	0.74	0.00	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.15	1.80	1.08	0.36	1.80	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.79	2.27	0.00	0.00	1.42	0.00	0.00	0.57	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	11.82	4.33	0.00	0.79	0.39	0.00	0.00	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	16.76	2.29	0.76	1.52	3.56	0.00	0.51	0.76	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	21.96	0.40	2.80	2.00	0.40	0.00	0.00	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	2.51	2.93	2.93	2.93	0.00	0.00	0.00	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	22.00	2.29	1.83	0.92	1.83	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	3.87	0.34	0.34	0.17	0.17	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor2	11368-117I9	17.94	0.34	0.50	1.51	0.84	0.50	0.84	0.00	0.00	0.34
Synoviocyte, donor3	11440-118H9	15.19	0.45	0.45	2.23	0.67	0.00	0.22	0.00	0.00	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	10.72	1.79	0.00	0.00	1.07	0.00	0.00	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	1.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	10.19	1.16	1.16	0.46	0.46	0.00	0.00	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	4.44	2.94	0.43	0.29	0.50	0.22	0.14	0.86	0.22	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	5.03	2.32	0.39	0.00	1.16	0.39	0.39	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	2.86	0.00	0.00	0.00	0.00	0.00	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.30	4.55	3.81	5.54	1.23	2.46	1.60	0.37	1.11	0.25
Urethra, donor2	10319-105A4	52.15	7.19	3.60	0.00	1.80	0.00	1.80	0.00	1.80	3.60
Urothelial Cells, donor1	11520-119H8	4.52	2.92	0.53	0.00	1.33	0.00	0.00	1.06	0.27	0.27
Urothelial Cells, donor2	11600-120H7	7.21	2.40	0.40	0.00	1.20	0.00	0.00	0.40	0.00	0.80
Urothelial Cells, donor3	11681-122H7	5.04	3.44	0.69	0.23	0.92	0.00	0.00	0.23	0.23	0.69
Urothelial cells, donor0	11216-116B1	5.13	1.78	0.00	0.00	1.34	0.00	0.00	0.89	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.02	3.56	3.56	13.35	1.78	0.00	29.36	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	5.72	8.58	18.58	2.86	4.29	55.75	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.74	3.42	0.68	9.58	0.00	1.37	27.38	1.37	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	29.61	3.10	5.17	12.05	1.38	0.69	23.41	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.89	2.32	4.65	11.62	4.65	0.58	19.17	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	27.07	1.04	2.08	7.29	0.00	3.12	31.24	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	30.29	1.84	3.67	10.10	0.92	2.75	23.86	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	25.56	1.83	2.74	3.65	1.83	1.83	28.30	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	15.05	8.76	2.34	0.49	0.12	1.11	0.00	1.73	0.62	0.12
Wilms' tumor cell line:HFWT	10597-108E3	4.40	0.88	18.48	1.76	0.00	2.64	2.64	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	3.91	8.38	1.68	1.12	0.56	1.12	0.00	1.40	1.68	0.28
achilles tendon, donor2	10292-104G4	28.93	8.27	2.07	4.13	2.07	0.00	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	4.59	10.20	2.55	2.29	1.02	1.78	5.35	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.84	27.16	6.97	7.66	0.00	0.93	3.71	1.16	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	4.99	14.13	2.73	7.72	0.12	0.36	2.97	0.95	0.00	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	12.25	16.33	0.00	2.99	0.82	0.00	0.82	0.54	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	5.34	14.90	7.59	1.69	0.56	2.25	3.37	3.37	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.40	21.78	4.65	3.81	1.69	0.85	2.11	3.38	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.96	18.51	4.36	1.63	3.54	3.27	1.63	3.54	3.54	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	19.39	14.54	4.85	3.08	3.53	0.88	0.44	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	33.89	28.18	7.35	3.27	2.45	0.00	4.08	1.23	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	41.16	24.46	8.15	5.44	3.11	0.78	4.27	0.78	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	15.64	12.51	1.66	0.74	0.37	0.74	0.18	1.84	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	23.40	27.30	3.90	3.90	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	15.80	28.35	2.09	2.79	2.09	0.70	1.86	5.11	0.93	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	24.34	9.06	3.62	1.04	0.78	0.52	1.04	0.52	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	34.78	9.06	2.63	0.88	1.17	1.46	1.75	1.46	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	32.07	8.83	4.18	1.39	1.39	5.11	2.32	1.39	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	41.95	15.22	9.87	1.65	2.47	2.47	3.70	1.65	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	17.50	4.30	2.46	0.92	0.92	1.53	0.92	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.88	14.93	2.13	3.41	2.13	0.43	1.71	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	35.49	10.92	1.52	3.94	0.91	0.30	0.00	0.91	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	27.20	13.96	1.44	3.85	1.20	0.72	1.68	0.00	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	27.84	9.80	2.00	0.45	1.78	1.78	0.45	1.56	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.01	5.67	2.67	1.33	2.00	0.67	0.67	1.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	14.87	7.43	3.72	0.00	0.00	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	24.48	7.53	2.26	1.88	0.75	0.38	1.51	1.51	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	15.26	18.75	13.52	3.49	0.44	3.93	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	52.48	20.62	11.25	0.00	0.00	0.00	1.87	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	16.96	16.25	1.41	4.00	0.71	0.00	0.47	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	32.89	2.33	1.24	2.79	1.86	0.31	0.62	0.31	0.31	0.00
adipose, donor1	10184-103D4	8.80	15.83	2.93	1.17	0.00	0.00	0.00	3.52	3.52	0.00
adipose, donor2	10185-103D5	8.52	4.06	3.24	0.41	0.00	0.41	0.00	1.22	0.81	0.00
adipose, donor3	10186-103D6	13.89	4.63	7.08	0.27	0.27	3.81	0.00	0.82	2.72	0.00
adipose, donor4	10187-103D7	9.53	4.33	2.60	0.00	0.00	2.60	0.00	0.87	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	20.67	6.63	0.79	0.63	0.00	0.00	0.16	1.26	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	29.10	0.00	3.64	0.00	3.64	0.00	7.28	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.47	9.87	3.20	4.67	0.13	1.47	4.27	0.67	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	19.29	8.22	3.57	0.71	1.07	1.07	0.00	3.22	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	7.65	1.62	0.93	0.93	0.00	0.46	0.00	0.00	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	10.14	2.03	1.01	1.35	0.00	0.34	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	10.31	0.00	0.59	0.00	0.00	1.18	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	67.59	8.30	15.42	1.19	2.37	2.37	0.00	0.00	0.00	2.37
amygdala, adult, donor10252	10151-102I7	88.41	4.46	9.53	1.42	6.08	2.64	0.81	1.82	0.81	1.01
amygdala, newborn, donor10223	10360-105E9	34.86	1.94	3.55	1.29	3.87	0.65	0.00	0.32	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	19.48	4.84	0.25	1.78	1.40	0.00	1.02	0.64	0.25	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	4.63	6.18	2.65	2.87	0.66	2.21	7.94	0.88	0.88	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	47.77	27.73	5.68	1.67	2.67	0.33	1.34	4.01	0.33	1.00
aorta, adult, pool1	10052-101G7	20.20	2.55	1.37	1.57	0.39	0.00	0.98	0.59	0.39	0.39
appendix, adult	10189-103D9	45.41	10.87	8.54	9.31	4.66	2.33	7.76	1.16	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	12.73	15.48	3.10	0.34	0.34	1.72	1.03	0.34	0.34	0.00
artery, adult	10190-103E1	99.18	6.79	1.36	0.00	6.79	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	6.23	15.36	4.49	1.74	0.58	1.30	0.43	2.75	0.72	0.29
b cell line:RPMI1788	10427-106D4	16.06	14.13	2.97	8.62	1.04	0.74	9.37	0.74	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	8.88	0.55	0.28	0.00	0.83	0.00	0.28	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	8.14	8.43	1.39	1.69	0.50	0.30	0.20	0.69	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	0.17	0.17	0.84	0.33	0.17	0.17	0.50	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	38.59	0.56	3.91	1.12	1.68	3.91	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	36.29	3.04	1.63	3.69	2.50	1.09	1.30	0.22	0.11	0.22
blood, adult, pool1	10053-101G8	13.29	2.21	2.21	0.00	2.21	0.00	8.86	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	5.14	0.86	0.86	0.86	0.00	0.00	1.71	0.86	0.00
bone marrow, adult	10192-103E3	33.74	5.40	0.67	3.37	6.07	0.00	1.35	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	55.35	4.10	9.23	2.05	3.08	4.10	1.03	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	49.00	4.45	6.12	0.33	2.12	2.00	0.33	1.56	0.56	0.78
brain, fetal, pool1	10085-102B4	48.09	2.67	13.36	0.00	2.67	0.00	2.67	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	0.00	0.00	5.95	0.00	0.00	0.99	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	16.85	2.75	11.86	0.50	2.00	6.12	0.37	1.00	1.62	0.00
breast, adult, donor1	10080-102A8	18.31	0.63	2.53	0.00	0.63	1.26	0.63	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.27	18.29	1.02	1.02	0.89	0.38	0.38	6.22	2.67	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	11.75	5.26	3.09	4.02	0.62	0.62	1.86	1.55	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	10.13	13.58	0.23	1.84	0.92	0.23	0.23	0.46	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.00	0.24	3.15	0.00	0.00	1.21	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	13.16	7.05	5.17	0.00	0.94	0.94	0.00	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	10.83	7.11	1.53	1.42	0.44	1.31	1.64	0.88	0.33	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	21.87	4.75	1.58	0.32	0.95	0.63	0.00	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	14.64	1.86	10.11	0.00	0.27	1.86	0.00	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	80.59	4.61	17.27	1.15	4.61	5.76	2.30	1.15	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	75.97	6.69	9.04	2.01	4.52	2.68	0.17	1.51	0.84	0.84
caudate nucleus, adult, donor10258	10379-105H1	84.06	1.53	16.05	0.00	3.82	3.82	0.00	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	34.06	4.76	10.99	1.46	4.76	1.83	0.00	1.10	3.30	0.73
cerebellum - adult, donor10196	10173-103C2	125.27	2.91	26.22	0.00	2.91	11.65	2.91	8.74	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	126.40	8.11	36.94	2.56	5.12	26.05	1.07	2.35	0.43	0.21
cerebellum, adult, pool1	10083-102B2	61.06	5.52	15.18	0.69	3.10	6.90	0.34	2.07	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	97.14	12.45	47.33	0.83	0.83	23.25	0.00	1.66	2.49	0.00
cerebral meninges, adult	10188-103D8	45.13	3.28	3.78	1.26	2.77	0.25	0.50	0.50	1.51	0.25
cerebrospinal fluid, donor2	10294-104G6	49.70	1.46	5.12	0.73	4.39	0.00	0.00	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	0.00	0.00	1.58	0.00	0.00	0.29	0.00	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	10.94	7.95	2.65	2.15	2.32	1.33	2.15	1.66	0.33	1.16
cervix, adult, pool1	10013-101C4	34.02	4.72	3.57	1.57	3.04	1.89	1.05	1.36	0.84	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	4.88	1.25	0.14	0.28	0.00	0.28	0.14	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	0.00	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	10.44	12.30	3.73	1.74	0.62	0.99	2.73	1.62	6.71	0.25
choriocarcinoma cell line:SCH	10785-110H2	3.57	6.41	0.37	1.36	0.12	0.12	0.62	0.62	1.97	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	3.79	3.79	2.61	0.24	0.00	1.19	0.00	0.24	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	9.69	6.55	0.28	1.71	0.28	0.28	0.85	0.28	1.42	0.00
chorionic membrane cells, donor2	12239-129G7	8.15	2.39	0.50	0.89	0.50	0.00	0.40	0.50	0.40	0.00
chorionic membrane cells, donor3	12240-129G8	9.89	5.49	0.00	2.75	0.00	1.65	2.75	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	14.14	1.01	0.00	1.01	1.01	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	17.29	7.11	4.03	0.58	1.92	1.54	0.58	0.77	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	16.05	6.76	3.80	0.21	0.42	1.48	1.27	2.11	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	5.14	7.70	1.54	0.51	0.00	0.26	0.26	1.80	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	5.56	7.98	1.21	0.48	0.00	0.73	0.97	1.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.05	4.89	1.43	1.43	0.20	0.00	0.20	1.02	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	7.07	15.61	1.18	0.88	0.00	0.29	0.00	1.77	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	32.06	21.11	11.47	3.91	1.82	1.82	1.82	4.43	0.26	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	2.97	9.37	1.14	0.69	0.46	0.23	0.69	1.60	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	3.64	6.42	1.21	3.30	0.00	0.52	1.56	1.04	2.60	0.00
colon carcinoma cell line:CACO-2	10513-107D9	7.69	8.24	1.28	0.18	0.00	0.37	0.00	1.10	4.21	0.00
colon carcinoma cell line:COLO-320	10420-106C6	15.96	25.09	3.42	1.14	0.38	4.18	0.00	1.52	0.00	0.00
colon, adult, donor1	10082-102B1	72.59	20.23	5.95	7.14	3.57	4.76	1.19	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	45.71	10.34	3.17	4.23	1.65	1.88	2.70	0.82	0.12	0.12
colon, fetal, donor1	10070-101I7	33.99	9.27	4.94	4.94	3.09	3.71	0.62	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	151.26	27.50	73.34	13.75	9.17	18.33	32.08	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	5.10	0.42	3.82	1.70	0.42	4.25	4.67	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3.92	4.08	2.41	2.41	0.60	1.06	2.41	0.00	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	6.49	2.96	2.96	2.96	0.28	0.99	1.83	0.28	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	62.03	10.06	15.37	2.87	7.08	2.65	1.77	2.87	4.20	0.88
cruciate ligament, donor2	10295-104G7	33.23	3.24	2.43	1.62	0.81	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	99.52	6.42	7.22	0.00	7.22	3.21	0.80	0.00	0.00	0.80
diencephalon, adult	10193-103E4	33.12	2.88	5.28	0.72	3.84	1.68	0.96	1.20	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.38	14.01	2.30	3.90	0.46	1.38	1.61	0.46	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	5.64	2.82	2.56	2.31	0.51	0.77	0.51	0.51	1.03	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	10.59	9.63	1.44	0.48	0.48	0.72	0.96	1.93	1.69	0.24
ductus deferens, adult	10196-103E7	50.33	7.97	4.98	2.99	4.98	2.49	0.50	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	11.52	1.44	2.88	1.44	0.00	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	48.55	8.09	11.77	5.89	2.94	5.15	2.21	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	32.13	2.31	1.98	0.58	1.90	0.83	0.33	0.25	0.33	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.00	6.66	7.77	0.22	0.89	5.33	0.22	0.89	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6.02	2.44	2.01	0.00	0.43	0.86	0.00	0.14	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	12.95	1.85	1.23	0.00	0.62	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	13.02	2.42	1.51	0.61	0.30	0.30	0.00	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	13.89	3.40	1.23	0.62	0.00	1.23	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	15.76	2.63	2.63	0.00	0.00	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	4.02	4.36	1.68	1.34	0.00	1.01	1.68	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	14.86	6.89	0.54	0.54	1.09	0.18	0.18	0.91	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	3.86	3.22	0.96	0.00	0.00	0.00	0.00	1.13	0.64	0.00
epidermoid carcinoma cell line:A431	10426-106D3	7.11	4.45	0.89	1.11	0.78	0.44	1.33	0.67	0.11	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	7.37	3.85	1.21	1.65	0.33	0.99	0.55	0.33	0.77	0.55
epididymis, adult	10197-103E8	38.09	9.00	3.35	3.98	2.72	1.26	1.26	0.42	0.63	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	3.55	0.89	0.53	0.53	0.00	0.18	0.00	0.18	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	6.29	2.75	0.79	0.79	0.39	0.79	0.79	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.00	0.00	2.49	0.13	0.00	1.44	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.00	0.10	1.18	0.00	0.00	2.95	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.00	0.00	2.13	0.00	0.00	1.90	0.00	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	33.55	4.03	2.12	2.23	4.57	1.81	0.64	0.32	0.64	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	12.02	7.89	28.80	0.25	0.25	12.15	0.25	1.13	3.01	0.13
eye - muscle inferior rectus, donor1	10272-104E2	96.58	0.00	4.83	0.00	7.24	2.41	2.41	0.00	7.24	0.00
eye - muscle lateral, donor2	10298-104H1	168.34	8.42	6.31	0.00	6.31	4.21	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	156.26	0.00	5.95	0.00	7.44	2.98	4.46	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	85.99	0.00	5.73	4.59	0.00	4.59	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	4.37	0.00	0.00	2.91	0.00	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	32.54	3.31	6.10	0.76	1.53	0.51	0.00	0.51	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	7.31	5.90	1.41	0.26	0.13	0.13	0.00	0.64	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	7.83	6.41	0.47	0.47	0.24	0.24	0.00	1.19	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	57.33	6.38	7.88	1.03	3.00	1.78	0.19	1.97	1.03	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.51	3.90	5.70	4.50	0.60	2.70	3.00	0.90	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	0.73	0.09	0.91	0.46	0.00	0.27	0.00	0.00	0.00	0.00
gall bladder, adult	10198-103E9	39.11	4.59	1.69	3.14	3.38	0.48	1.45	0.48	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	39.73	6.44	8.05	11.81	3.76	1.61	10.20	0.54	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	38.84	0.75	7.10	8.59	4.11	2.24	5.60	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	26.19	7.39	1.06	3.59	0.84	1.48	2.96	1.06	0.63	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	6.58	1.93	0.77	0.19	0.00	0.00	0.00	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	14.92	8.36	0.66	0.33	0.33	0.16	0.00	1.31	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	12.81	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	3.43	0.00	3.66	0.00	0.00	0.69	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	3.44	1.84	1.26	1.03	0.00	0.57	0.69	0.23	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	5.60	7.28	0.14	0.42	0.42	0.14	0.14	0.42	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	0.00	0.00	0.00	0.00	0.00	0.25	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	6.76	5.38	0.74	0.95	0.32	0.21	0.21	0.74	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.16	6.46	0.70	0.70	0.28	0.14	0.14	1.26	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	13.36	8.61	1.10	1.77	1.21	0.77	0.33	0.99	0.11	0.22
glioma cell line:GI-1	10413-106B8	9.96	2.64	0.88	0.00	0.29	0.00	0.00	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	99.86	5.10	12.39	1.46	10.20	2.92	2.92	0.73	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	87.63	6.59	9.28	3.42	8.30	3.66	2.20	2.69	3.42	2.44
globus pallidus, adult, donor10258	10367-105F7	128.71	6.85	12.32	1.37	8.22	5.48	0.00	1.37	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	36.24	2.13	11.19	2.13	4.26	2.66	0.00	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	129.70	34.26	39.15	12.24	2.45	7.34	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	0.00	0.00	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	10.45	0.00	5.23	0.00	0.00	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	9.28	5.12	0.32	0.64	0.32	0.32	0.32	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	5.51	5.51	3.21	0.00	0.00	0.46	0.92	0.00	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	12.80	3.66	1.83	0.00	0.00	0.46	1.37	0.00	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	7.73	3.86	4.51	0.00	0.64	1.93	0.64	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	7.19	1.44	4.31	0.00	1.44	2.87	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.17	2.06	1.37	0.00	0.00	0.00	0.00	0.69	1.37	0.00
hIPS, biol_rep3	14382-156B8	87.17	5.52	12.14	0.00	6.62	3.31	1.10	0.00	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	12.93	7.18	5.75	0.86	2.87	1.15	2.01	0.00	0.29	0.86
heart - mitral valve, adult	10205-103F7	63.08	11.36	2.09	1.49	6.58	1.79	0.60	1.49	1.20	0.00
heart - pulmonic valve, adult	10206-103F8	95.96	17.00	2.88	0.78	9.67	0.00	0.78	2.35	1.57	1.05
heart - tricuspid valve, adult	10207-103F9	38.30	5.83	0.00	0.83	1.67	3.33	1.67	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	55.71	11.02	2.24	1.02	4.08	1.02	0.41	1.63	0.82	0.61
heart, adult, diseased, donor1	10051-101G6	134.56	20.44	3.83	1.28	12.77	1.70	0.43	2.55	1.70	1.28
heart, adult, pool1	10016-101C7	59.56	10.81	1.38	1.38	5.06	0.23	0.23	0.46	0.46	1.38
heart, fetal, pool1	10046-101G1	87.79	53.29	4.62	2.46	7.60	1.33	0.82	3.90	1.54	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	7.40	0.93	0.31	0.93	0.31	0.31	0.00	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	9.51	4.76	1.19	0.00	2.38	0.00	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	6.19	9.06	0.55	1.55	0.44	0.33	0.88	0.66	0.33	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	6.55	9.10	0.12	0.73	0.12	0.00	0.97	1.58	0.24	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	6.57	8.79	0.40	2.02	0.20	0.10	0.61	1.82	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	5.23	5.78	1.56	1.45	0.00	0.44	1.45	0.67	0.22	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.86	26.83	3.12	12.36	0.20	1.81	13.07	1.51	0.50	0.30
hippocampus - adult, donor10196	10169-103B7	72.87	0.00	8.52	0.95	6.62	1.89	0.00	0.00	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	91.23	6.74	6.33	1.63	5.51	4.49	0.61	2.45	2.45	1.22
hippocampus, adult, donor10258	10374-105G5	71.70	1.00	13.44	0.50	2.99	1.49	0.00	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	24.32	1.41	8.11	0.00	4.58	2.47	0.35	0.00	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	8.54	13.43	0.00	0.00	0.00	1.22	0.00	1.83	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.89	7.27	4.12	0.79	0.00	2.16	0.39	1.18	1.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	2.79	5.84	3.05	0.00	0.00	1.52	0.25	1.02	1.27	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.02	7.33	5.64	0.00	0.00	0.56	0.00	2.82	5.64	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5.16	15.49	3.87	0.77	0.00	2.58	0.26	2.07	5.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	8.73	12.53	3.04	0.38	0.00	1.52	0.38	2.66	6.45	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	12.85	6.42	14.89	0.00	0.88	6.13	0.00	2.63	5.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	8.19	7.32	13.36	0.00	0.22	5.39	0.00	1.29	3.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.18	6.26	15.43	0.00	0.00	6.67	0.00	2.09	2.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.23	3.32	6.16	0.00	0.00	2.13	0.00	2.13	2.60	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	10.93	6.11	8.52	0.48	0.48	3.70	0.00	2.25	4.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.77	5.39	8.75	0.00	0.00	3.37	0.00	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3.13	5.79	3.29	1.10	0.31	0.94	0.78	1.88	0.78	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	4.91	3.44	3.93	1.47	0.00	1.47	0.98	0.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2.62	7.85	5.24	3.49	0.00	0.00	0.87	1.75	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	9.16	7.45	7.25	0.57	0.00	2.29	0.19	1.91	2.86	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6.98	5.23	3.92	0.00	0.00	1.74	0.00	1.74	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	13.99	10.99	5.50	0.00	0.00	0.00	0.00	2.00	3.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	7.16	6.03	3.77	0.00	0.00	0.19	0.00	0.57	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	9.55	5.91	2.27	0.00	0.00	0.91	0.00	0.00	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	9.71	3.45	3.45	0.31	0.31	0.94	0.00	1.25	1.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	12.25	6.21	4.41	0.16	0.49	0.82	0.00	2.12	1.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.13	4.64	4.35	0.00	0.00	0.87	0.00	0.87	2.03	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	13.15	4.48	6.88	0.00	0.60	0.60	0.00	2.39	2.09	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.99	6.84	3.33	0.37	0.00	1.29	0.18	1.85	0.74	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	4.28	6.28	5.99	0.29	0.00	1.43	0.00	1.14	2.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5.31	10.62	3.67	0.00	0.82	1.22	0.41	2.86	3.67	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.86	10.21	1.41	0.00	0.00	0.00	0.00	1.41	2.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.65	7.60	4.12	0.00	0.00	1.90	0.00	1.27	2.22	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	9.68	8.17	3.33	0.00	0.30	0.91	0.00	1.51	3.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	2.59	6.21	0.00	0.00	3.62	0.00	1.55	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	8.63	6.64	6.64	0.00	0.00	1.99	0.00	1.99	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.24	3.85	4.10	0.26	0.00	0.77	0.00	0.00	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.46	2.81	1.79	0.51	0.00	1.28	0.00	1.28	1.02	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	14.39	3.79	3.79	0.00	0.00	2.27	0.00	1.51	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.41	2.69	4.70	0.34	0.00	1.34	0.00	0.67	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	4.83	7.00	4.59	0.00	0.00	2.42	0.00	1.69	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6.68	5.79	3.12	0.00	0.00	1.34	0.00	2.67	2.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.29	7.80	2.93	0.00	0.00	1.46	0.00	2.93	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	9.17	4.28	7.03	0.00	0.00	1.22	0.00	1.22	2.75	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	35.79	0.00	0.00	0.00	0.00	0.00	9.76	13.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	7.94	8.27	6.95	0.33	0.66	1.32	0.33	1.99	12.91	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	16.97	7.11	10.95	0.55	0.00	1.09	0.00	1.09	3.28	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	8.69	8.32	4.70	0.36	0.00	2.53	0.36	0.36	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.54	4.63	5.34	0.71	0.71	3.20	0.00	0.71	2.85	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	2.39	10.74	0.00	0.00	3.58	0.00	0.00	5.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.62	4.60	9.89	0.00	0.27	2.84	0.00	1.76	5.28	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.43	4.04	8.35	0.00	0.27	1.89	0.27	1.62	4.31	0.00
immature langerhans cells, donor1	11904-125F5	7.02	1.45	1.21	0.00	0.00	0.48	0.48	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	26.93	0.79	2.38	3.17	3.17	2.38	2.38	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	70.69	6.53	7.85	1.42	4.54	3.50	0.28	0.76	1.04	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	6.50	1.30	1.95	0.98	1.63	0.65	0.33	0.65	0.33	0.98
kidney, adult, pool1	10017-101C8	36.05	8.91	1.60	2.70	1.10	0.30	0.40	1.60	0.70	0.40
kidney, fetal, pool1	10045-101F9	46.47	19.81	5.02	3.89	2.33	0.57	1.27	1.84	0.57	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	9.66	3.98	2.70	0.28	0.00	0.28	0.00	0.28	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	3.73	0.41	0.55	0.00	0.41	0.28	0.28	0.00	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	0.92	0.18	3.49	0.00	0.00	1.83	0.00	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	55.57	13.62	2.72	1.63	6.54	0.00	0.54	2.18	0.00	0.00
left ventricle, adult, donor1	10078-102A6	62.70	3.54	2.02	0.00	2.53	0.00	0.00	0.00	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	8.48	9.58	2.74	0.27	0.27	1.92	0.82	5.20	1.92	0.00
leiomyoma cell line:10964C	10569-108B2	19.04	3.59	1.44	0.00	2.16	0.00	0.72	0.36	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	6.52	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	14.08	2.19	0.00	0.49	0.97	0.00	0.00	0.24	0.24	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	4.18	0.00	0.00	2.09	0.00	2.09	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.92	2.13	6.73	0.59	1.06	1.30	0.94	0.59	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	29.84	5.78	0.47	0.78	1.72	0.16	0.78	1.25	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	19.25	4.26	4.26	0.49	1.46	1.95	0.12	0.85	0.49	0.12
liver, adult, pool1	10018-101C9	15.72	1.46	1.13	1.30	1.13	0.49	0.65	0.00	0.00	0.00
liver, fetal, pool1	10086-102B5	7.53	2.82	0.94	0.00	0.00	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	71.75	4.37	11.08	1.02	5.40	2.48	0.44	1.90	0.87	0.73
locus coeruleus, adult, donor10252	10165-103B3	73.45	5.72	9.04	1.48	7.75	3.32	0.74	2.03	2.21	1.29
locus coeruleus, adult, donor10258	10375-105G6	68.28	3.39	10.44	1.13	2.54	1.97	1.69	1.69	1.41	0.85
locus coeruleus, newborn, donor10223	10362-105F2	31.13	5.89	11.78	0.42	4.21	2.10	0.42	1.26	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	7.47	2.91	0.28	0.14	0.14	0.00	0.00	0.14	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	3.45	2.07	2.07	0.69	0.00	0.00	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	0.00	0.00	0.53	0.13	0.00	0.26	0.00	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	20.20	4.73	2.72	3.19	1.06	1.06	2.84	0.00	0.00	0.00
lung, fetal, donor1	10068-101I5	41.67	7.14	8.56	4.85	2.00	2.57	2.00	0.86	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	29.78	4.12	1.83	3.21	0.46	2.29	3.21	0.92	0.00	0.00
lymph node, adult, donor1	10077-102A5	23.67	3.31	2.84	4.73	1.89	0.47	0.47	0.00	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	9.64	3.95	2.19	0.66	0.66	0.88	4.60	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	5.58	9.06	2.26	4.83	0.15	0.30	1.06	0.15	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	8.49	5.10	0.00	1.70	0.00	0.85	4.25	2.55	1.70	0.00
mature adipocyte, donor1	12231-129F8	53.28	0.00	1.33	0.00	0.00	0.44	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	46.07	0.00	0.62	0.62	1.04	0.21	0.21	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	45.75	0.24	0.71	0.24	0.71	0.24	0.00	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	29.74	0.53	0.53	0.00	0.26	0.53	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	7.39	1.67	1.91	0.00	0.00	0.00	0.24	0.48	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	93.63	2.26	9.02	0.00	3.38	3.38	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	83.68	6.07	11.77	1.84	6.07	4.78	0.74	2.21	2.39	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	69.26	3.18	6.67	0.32	3.81	2.86	0.64	1.59	0.95	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	34.12	4.26	2.99	0.00	7.68	0.85	0.00	0.00	0.85	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	84.88	6.75	9.62	1.01	4.56	3.54	1.01	2.36	0.84	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	92.95	6.58	11.46	2.33	6.58	5.31	0.21	2.76	2.76	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	57.79	3.85	11.56	0.00	7.71	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	33.02	2.51	5.74	1.44	2.87	2.15	0.36	1.08	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	66.84	5.19	14.28	3.24	9.73	3.89	3.89	4.54	2.60	0.65
medulla oblongata, adult, donor10252	10155-103A2	66.41	11.15	11.15	2.32	5.42	3.72	0.93	2.63	6.66	0.46
medulla oblongata, adult, pool1	10038-101F2	53.47	6.04	12.16	2.69	5.39	3.27	1.47	3.10	3.18	0.90
medulla oblongata, newborn, donor10223	10361-105F1	28.12	5.90	13.54	1.04	3.12	6.25	0.69	1.39	2.78	0.69
medulloblastoma cell line:D283 Med	10838-111E1	11.29	12.62	7.53	0.44	0.66	2.21	0.22	1.99	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	2.57	4.65	0.73	0.37	0.12	0.24	0.12	1.35	1.22	0.24
melanoma cell line:COLO 679	10514-107E1	1.01	1.58	3.16	0.14	0.00	2.30	0.00	1.15	0.57	0.00
melanoma cell line:G-361	10465-106H6	0.81	1.90	1.63	0.27	0.00	1.09	0.00	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	8.14	2.53	0.54	2.35	0.54	0.18	0.72	0.18	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	18.50	12.34	17.62	0.00	2.64	7.93	0.00	1.76	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	15.81	2.85	2.07	0.52	2.07	1.81	0.00	0.26	0.26	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.36	3.38	0.15	0.31	0.31	0.00	0.00	0.15	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.00	2.91	0.00	0.00	1.09	0.00	0.00	0.36	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.98	2.48	0.00	0.83	0.83	0.00	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.01	0.98	0.28	0.14	0.28	0.00	0.14	0.00	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.95	3.27	0.19	0.39	0.96	0.19	0.19	0.58	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	30.54	1.39	0.00	3.47	2.78	0.00	0.00	0.69	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.27	2.92	0.86	1.54	0.69	0.00	0.69	0.34	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.84	2.42	0.46	0.46	0.35	0.00	0.12	0.12	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	12.73	6.23	0.27	0.13	1.19	0.13	0.00	0.93	0.40	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	12.15	3.51	0.41	0.14	0.54	0.14	0.00	0.81	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	5.26	3.84	0.00	0.14	0.28	0.00	0.00	0.85	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	21.74	2.63	0.66	3.62	1.65	0.00	0.99	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	8.03	5.53	0.42	0.83	0.69	0.00	0.00	0.28	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.92	8.03	0.00	0.70	2.09	0.00	0.35	1.40	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.41	1.84	0.00	0.20	0.82	0.00	0.00	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	13.66	1.08	0.00	0.36	1.08	0.00	0.72	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.00	3.10	0.10	0.10	0.62	0.00	0.00	0.21	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2.51	1.14	0.46	0.00	0.68	0.23	0.00	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	5.45	3.36	0.42	0.00	2.52	0.00	0.00	1.26	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.31	4.03	0.30	0.75	1.64	0.00	0.00	0.15	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.70	5.51	0.09	0.18	0.44	0.09	0.18	0.96	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.25	6.26	0.00	0.00	1.47	0.00	0.37	1.10	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	9.44	1.43	0.00	0.29	0.57	0.00	0.29	0.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	6.74	2.53	1.26	0.84	0.00	0.00	0.00	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	14.61	2.28	0.46	0.00	1.83	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.11	2.30	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.18	2.36	0.00	0.00	0.79	0.00	0.00	0.00	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.02	1.23	0.31	0.31	0.62	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.18	3.06	0.00	0.00	1.18	0.00	0.00	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.85	2.03	0.34	0.00	0.68	0.00	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.36	3.93	0.00	1.18	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.34	3.24	0.00	0.00	0.46	0.00	0.00	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.86	5.48	0.00	0.58	0.29	0.58	0.00	0.58	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.94	2.90	0.45	0.22	0.67	0.00	0.22	0.22	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.18	3.12	0.72	0.24	1.92	0.24	0.00	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	10.27	0.73	0.00	0.73	0.73	0.00	0.00	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	16.78	1.68	0.00	0.00	1.34	0.34	0.00	0.00	0.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	18.42	3.28	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.89	2.58	0.86	0.00	2.58	0.43	0.00	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	8.20	0.00	2.73	2.73	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.29	1.30	0.32	0.32	1.30	0.00	0.00	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	32.01	2.91	0.00	0.00	0.00	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.19	4.26	0.00	0.53	1.07	0.00	0.53	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	1.64	0.00	1.64	0.00	0.00	0.00	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.83	2.33	0.00	0.39	1.17	0.00	0.00	0.78	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	0.00	0.00	0.00	0.00	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	25.83	3.97	0.00	0.00	0.00	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.20	3.56	0.00	0.00	1.78	0.59	0.59	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	4.87	1.22	0.00	0.00	0.00	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	2.53	0.00	0.00	1.27	0.00	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.11	0.69	0.00	0.00	0.00	0.00	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.85	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	10.33	2.38	0.79	0.79	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.33	1.18	0.00	0.00	0.00	0.00	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.65	0.31	0.31	0.31	0.31	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	2.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	0.00	0.00	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.78	0.00	0.00	0.69	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	27.21	0.49	0.99	0.00	0.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	2.24	1.12	0.00	1.12	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	20.99	0.00	1.27	0.64	0.00	0.00	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	26.60	1.21	2.82	0.00	2.42	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	39.25	2.18	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	0.00	1.27	0.00	1.27	0.00	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	35.81	2.43	0.00	0.61	3.03	0.00	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.12	1.65	1.65	2.47	0.82	0.82	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.20	0.99	0.00	1.19	0.99	0.00	0.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.71	0.65	0.97	1.30	1.30	0.00	0.32	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	0.00	0.00	1.02	1.02	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	12.38	0.00	2.32	0.77	0.00	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	6.14	4.49	0.47	0.94	0.00	0.00	0.00	0.47	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	2.32	1.39	5.10	0.23	0.00	0.46	0.00	0.46	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.69	4.42	1.23	2.16	1.23	0.31	1.13	0.82	0.72	0.00
mesothelioma cell line:Mero-25	10850-111F4	3.18	3.18	0.45	0.45	0.00	0.00	0.68	0.23	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	5.62	1.71	0.24	0.00	0.24	0.00	0.00	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	1.99	1.55	0.00	0.00	0.00	0.22	0.00	0.44	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	8.94	4.99	0.53	3.15	1.05	0.53	1.84	0.00	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	6.98	1.87	0.34	0.00	0.17	0.17	0.17	0.00	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	3.03	3.79	0.00	0.00	0.25	0.00	0.00	0.25	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	14.91	6.21	0.83	0.62	0.41	0.00	0.21	1.24	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	5.14	5.14	0.17	0.00	0.83	0.50	0.00	0.50	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	5.61	3.98	0.18	0.00	0.18	0.00	0.00	0.72	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	5.98	5.64	0.17	0.85	0.51	0.00	0.85	0.85	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	2.80	5.85	0.00	0.76	0.25	0.00	0.00	1.02	0.00	0.00
mesothelioma cell line:No36	10857-111G2	11.74	2.94	0.98	0.65	1.30	0.33	0.33	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	4.34	1.90	0.00	0.27	0.27	0.00	0.27	0.27	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	7.68	3.26	1.15	4.03	0.19	0.38	1.73	0.19	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	6.47	3.79	1.34	1.59	0.24	0.00	0.73	0.24	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	15.44	8.62	3.23	3.95	0.54	0.90	3.23	0.72	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	11.75	1.96	0.65	0.65	0.33	0.00	0.65	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	0.00	0.00	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	3.69	5.30	2.07	1.15	0.00	0.92	0.92	0.00	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	6.66	6.28	3.62	4.95	0.76	1.90	4.95	0.19	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	34.74	10.16	2.59	3.88	1.11	1.48	2.22	0.74	0.00	0.00
myeloma cell line:PCM6	10474-106I6	29.85	10.28	0.79	10.08	2.97	0.59	5.14	0.79	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.42	1.77	1.18	0.59	1.18	0.78	0.59	0.39	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	1.67	0.45	0.56	0.00	0.33	0.11	0.00	0.22	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	1.91	1.25	0.29	0.07	0.07	0.07	0.07	0.00	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	7.18	1.10	0.55	0.00	0.00	0.55	0.00	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	36.35	9.66	4.14	0.00	2.07	1.84	0.00	0.69	0.00	0.46
neuroblastoma cell line:NB-1	10539-107G8	18.71	12.91	1.87	1.12	0.56	0.37	0.00	1.50	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	8.01	0.21	0.42	0.00	0.00	0.63	0.00	0.42	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	34.66	2.98	8.57	0.00	0.56	2.61	0.00	1.30	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.47	0.00	1.90	0.00	0.24	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	26.45	2.69	1.74	0.00	1.27	0.32	0.00	0.95	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	3.62	0.00	3.62	0.00	0.00	0.40	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.64	0.00	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	9.58	0.53	0.27	0.00	0.27	0.00	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	7.78	19.11	11.50	9.81	0.68	2.37	9.47	0.34	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.30	0.96	2.24	0.00	0.00	0.64	0.00	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	20.76	4.47	0.79	1.84	0.79	0.53	0.79	0.26	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	63.84	6.66	10.97	1.59	4.03	2.62	0.47	1.69	0.75	0.94
occipital cortex - adult, donor10196	10172-103C1	86.54	8.24	8.24	2.06	6.18	2.06	2.06	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	111.10	8.59	10.47	2.15	6.44	8.32	0.54	2.15	1.88	1.07
occipital cortex, newborn, donor10223	10355-105E4	38.58	2.91	6.19	0.00	3.28	2.55	0.00	1.09	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	47.76	4.99	2.89	0.52	3.41	0.79	0.26	1.31	1.31	0.52
occipital lobe, fetal, donor1	10073-102A1	26.60	1.29	10.30	0.43	1.72	3.86	0.00	0.00	0.43	0.00
occipital pole, adult, pool1	10036-101E9	57.08	7.73	5.60	1.58	3.63	1.42	0.24	1.97	0.63	0.79
olfactory region, adult	10195-103E6	59.99	3.82	11.46	1.53	3.63	1.72	0.76	1.34	1.15	0.76
optic nerve, donor1	10277-104E7	40.02	2.00	24.01	2.00	2.00	6.00	0.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	5.13	6.26	1.82	2.73	1.03	1.03	1.14	1.37	0.80	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.50	7.01	1.92	1.24	0.14	1.10	0.69	1.37	0.96	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	8.64	6.60	0.85	2.03	1.69	0.17	0.51	0.85	0.85	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	3.23	1.27	0.81	0.12	0.12	0.12	0.00	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	6.17	0.59	0.88	0.29	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	9.34	1.87	7.47	0.00	1.87	3.74	0.00	0.93	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	15.27	1.06	2.33	0.00	0.64	0.85	0.21	0.42	0.00	0.00
ovary, adult, pool1	10020-101D2	20.00	4.72	2.36	2.53	1.22	0.79	0.79	0.87	0.35	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.88	4.58	1.47	2.02	1.47	0.18	0.73	1.10	0.00	0.18
pancreas, adult, donor1	10049-101G4	19.75	8.47	0.94	1.88	0.94	0.94	0.94	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	7.83	5.31	5.87	0.84	0.28	1.96	0.56	0.84	2.24	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	7.67	3.07	0.85	0.17	1.19	0.34	0.34	0.34	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	6.79	12.92	0.99	6.13	0.17	0.66	1.32	1.32	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	55.37	6.22	7.96	1.10	2.47	2.01	0.18	1.65	0.92	1.01
parietal cortex, adult, donor10258	10373-105G4	49.18	2.94	7.34	0.73	2.94	0.73	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	53.61	7.52	10.35	0.00	0.94	1.88	0.00	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	88.36	7.41	12.26	2.28	5.70	4.28	0.57	2.28	1.14	0.57
parietal lobe, adult, pool1	10034-101E7	60.98	5.73	8.46	2.11	3.88	2.03	0.44	1.94	1.23	0.97
parietal lobe, fetal, donor1	10072-101I9	31.03	0.00	14.55	0.00	2.91	3.88	0.00	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	32.90	1.87	5.61	0.75	4.11	1.50	0.75	0.75	0.37	0.37
parotid gland, adult	10199-103F1	29.60	5.55	4.32	0.62	2.47	3.70	0.00	0.00	1.23	0.00
penis, adult	10200-103F2	55.86	5.91	5.91	1.61	6.45	0.00	1.07	0.00	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.59	1.12	0.74	0.00	0.56	0.00	0.00	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.13	16.61	4.81	2.62	2.91	3.64	1.89	4.66	5.39	0.58
pineal gland - adult, donor10196	10179-103C8	61.92	2.58	6.45	0.65	1.29	1.29	0.00	1.94	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	67.51	8.29	8.29	2.37	2.37	2.37	0.00	1.78	1.78	1.18
pineal gland, adult, donor10258	10377-105G8	55.81	5.02	6.27	3.14	3.76	1.25	0.00	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	36.42	9.11	9.11	5.06	2.02	4.05	4.05	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	72.44	21.37	13.55	5.21	1.56	5.73	2.08	2.61	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	52.78	12.77	11.92	2.55	4.26	3.40	0.85	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	11.61	3.87	6.67	6.02	0.32	3.33	1.72	0.65	0.97	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	8.08	9.40	1.85	1.59	0.66	1.99	1.85	0.26	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	5.91	1.87	0.62	0.47	0.16	0.00	0.00	0.00	0.62	0.00
pons, adult, pool1	10033-101E6	43.81	4.30	9.38	1.38	3.44	2.41	0.34	1.29	1.89	0.34
postcentral gyrus, adult, pool1	10032-101E5	62.24	6.54	6.54	1.05	3.40	1.92	0.26	2.18	0.35	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	4.18	27.19	2.09	2.09	12.55	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	5.51	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	0.00	0.00	1.60	0.00	0.00	1.02	0.00	0.00	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	0.00	0.00	3.81	0.00	0.00	0.36	0.00	0.00	0.00	0.00
prostate, adult, pool1	10022-101D4	30.93	4.90	3.17	3.90	2.54	1.81	1.09	1.00	0.18	0.36
putamen, adult, donor10196	10176-103C5	77.43	4.96	11.80	0.47	6.61	2.83	0.47	1.65	0.47	1.65
putamen, adult, donor10252	10152-102I8	49.02	5.88	9.80	0.00	0.00	3.92	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	3.28	2.19	0.00	5.46	3.28	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	61.13	3.38	8.70	0.72	3.38	2.90	0.00	0.72	0.00	0.48
putamen, newborn, donor10223	10365-105F5	37.48	4.50	20.24	1.50	7.50	2.25	1.50	1.50	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	1.16	1.75	3.49	0.58	0.00	2.04	1.16	0.58	0.29	0.00
rectum, fetal, donor1	10067-101I4	58.42	6.95	12.52	2.78	8.35	12.52	1.39	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	3.60	4.45	0.42	0.64	0.00	0.00	0.00	0.42	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.15	1.66	1.24	1.66	0.00	0.83	3.73	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	42.94	7.55	5.37	2.58	2.68	1.19	0.50	0.80	0.20	0.00
retinoblastoma cell line:Y79	10475-106I7	22.08	18.97	11.69	0.00	0.00	2.86	0.00	1.82	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.31	8.48	1.11	0.98	0.49	0.37	0.61	1.84	0.37	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	7.31	0.56	1.97	0.00	0.00	1.69	0.00	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	25.77	0.76	1.52	2.27	1.52	0.00	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	12.95	1.78	2.75	0.97	3.88	2.75	0.00	0.49	0.49	1.13
salivary acinar cells, donor2	11772-123I8	14.73	1.79	2.20	0.28	2.89	1.24	0.00	0.41	0.14	0.55
salivary acinar cells, donor3	11773-123I9	21.85	0.66	1.99	1.99	2.65	0.66	0.00	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	62.91	12.58	4.00	4.00	3.43	3.43	1.72	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.93	12.39	0.34	0.67	2.36	0.08	0.08	1.52	0.34	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.87	11.28	0.35	0.82	1.88	0.12	0.00	1.76	0.24	0.71
seminal vesicle, adult	10201-103F3	58.73	10.05	13.23	4.23	4.23	7.41	1.06	2.65	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	4.13	1.21	3.40	0.73	0.24	0.97	0.24	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	6.54	1.76	1.01	0.25	0.75	0.50	0.00	0.75	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	2.01	3.01	2.01	0.00	0.00	0.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	10.21	5.91	3.09	1.07	0.40	0.40	0.27	2.01	7.79	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	5.75	5.75	1.22	2.10	0.11	0.44	0.44	0.77	0.33	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.65	0.77	0.90	0.13	0.00	0.90	0.13	0.13	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	300.05	7.80	2.13	0.00	26.25	2.84	0.00	1.42	0.00	2.13
skeletal muscle, adult, pool1	10023-101D5	111.42	11.75	1.44	0.72	7.56	1.08	0.12	0.72	0.48	0.72
skeletal muscle, fetal, donor1	10066-101I3	14.07	1.01	7.04	0.00	1.01	1.01	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	32.82	4.42	1.89	3.16	3.79	0.00	0.00	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	4.67	13.67	4.34	1.00	0.33	1.00	0.00	3.34	1.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	20.17	9.77	10.72	0.00	1.89	1.89	0.00	1.89	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	25.25	2.31	1.73	0.00	0.19	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	4.94	2.47	2.31	0.49	0.33	1.65	0.00	0.82	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	6.43	1.45	3.06	0.00	0.64	1.29	0.00	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.32	23.32	9.37	5.01	1.96	5.88	4.79	4.36	0.65	0.44
small intestine, adult, pool1	10024-101D6	27.11	8.60	3.34	10.51	1.55	2.63	4.78	1.07	0.48	0.24
small intestine, fetal, donor1	10064-101I1	21.62	5.65	4.18	3.69	0.25	0.98	2.70	0.74	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	9.75	2.05	0.51	0.00	0.51	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	55.31	4.65	4.91	1.29	3.62	3.62	0.00	0.78	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	0.00	0.00	1.07	0.00	0.00	0.54	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	59.19	4.82	12.62	1.61	6.88	3.44	1.15	2.06	1.84	0.23
spinal cord, adult, donor10252	10159-103A6	78.07	4.73	9.46	0.79	6.70	4.73	2.37	3.55	2.37	0.79
spinal cord, adult, donor10258	10369-105F9	79.56	2.77	15.91	0.69	13.84	4.15	2.08	2.08	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	44.52	6.71	6.71	1.83	1.22	2.44	0.61	2.44	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	31.69	5.51	9.18	0.92	2.76	3.21	1.38	2.76	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	4.48	0.75	0.15	0.15	0.15	0.00	0.00	0.30	0.00	0.15
spleen, adult, pool1	10025-101D7	27.53	7.27	2.75	4.52	2.86	1.10	2.97	0.55	0.22	0.22
spleen, fetal, pool1	10044-101F8	39.33	9.69	4.69	7.79	3.26	1.51	3.89	0.56	0.40	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.63	14.60	2.48	4.14	2.17	1.04	3.00	0.62	0.41	1.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	3.42	8.54	1.52	7.60	0.00	0.19	1.33	0.38	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	32.15	5.59	2.45	2.10	2.80	1.40	0.35	1.05	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	6.65	3.52	0.78	5.08	0.78	0.78	1.95	0.78	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	12.49	6.42	0.68	5.52	0.00	0.23	1.13	1.13	0.00	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	3.39	5.93	0.85	4.24	1.27	0.42	0.85	2.54	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	2.12	2.54	2.12	1.69	0.00	0.85	1.69	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	45.92	3.20	5.34	2.14	0.00	0.00	0.00	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	43.30	7.98	5.13	2.28	5.13	0.57	2.85	1.14	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	74.15	6.02	7.48	1.04	7.06	3.32	1.25	3.32	3.53	1.66
substantia nigra, adult, donor10258	10371-105G2	88.45	5.69	14.48	1.55	11.90	2.59	1.03	0.00	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	32.50	5.65	9.19	1.41	3.53	4.24	0.71	0.71	2.83	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	20.86	14.67	1.15	0.46	0.46	0.00	0.00	1.83	0.46	0.23
temporal lobe, adult, pool1	10031-101E4	62.56	6.19	6.95	0.68	3.22	3.39	0.34	1.61	1.10	1.02
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	22.08	1.42	4.27	0.00	0.71	2.85	0.00	0.00	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	21.10	1.32	3.96	1.32	2.20	0.00	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	19.55	0.35	0.00	1.05	1.75	0.00	0.70	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	26.71	0.38	0.00	1.14	1.53	0.00	0.38	0.00	0.00	0.76
tenocyte, donor3	11768-123I4	13.34	1.85	0.37	1.11	1.11	0.37	0.00	0.37	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1.70	4.42	1.53	0.85	0.00	0.85	0.34	1.36	0.68	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	3.70	4.62	2.31	0.00	0.00	1.39	0.00	0.31	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	5.58	13.64	4.03	0.15	0.00	1.39	0.31	3.41	3.41	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	2.79	6.22	2.67	0.38	0.00	0.89	0.13	3.30	7.87	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3.03	3.78	3.78	0.38	0.00	0.76	0.00	1.13	2.65	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.53	10.25	0.76	2.94	0.22	0.76	2.40	1.53	5.02	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	7.17	12.05	0.65	0.98	0.00	0.33	0.33	1.30	2.28	0.00
testis, adult, pool1	10026-101D8	26.31	8.70	4.19	1.40	1.83	2.25	0.43	3.11	1.07	0.21
testis, adult, pool2	10096-102C6	46.46	13.53	15.79	1.35	3.16	2.26	0.45	4.06	1.80	0.45
thalamus - adult, donor10196	10168-103B6	108.19	6.62	19.87	2.21	4.42	4.42	2.21	1.10	2.21	0.00
thalamus, adult, donor10252	10154-103A1	82.20	7.35	11.41	2.34	7.66	4.53	1.56	2.66	3.75	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	101.61	0.00	32.33	3.08	10.78	4.62	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	57.15	2.96	7.58	0.82	3.46	1.48	0.16	0.99	1.32	1.15
thalamus, newborn, donor10223	10366-105F6	32.22	3.45	9.78	1.15	2.30	2.88	0.58	0.58	1.15	0.58
throat, adult	10209-103G2	67.16	7.49	4.74	3.99	6.24	3.00	1.75	1.75	0.50	1.00
throat, fetal, donor1	10061-101H7	47.84	3.96	8.23	2.74	3.35	1.22	0.61	1.52	0.00	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	16.10	3.18	1.79	0.00	0.20	0.20	0.00	0.40	0.00	0.00
thymus, adult, pool1	10027-101D9	17.20	14.51	2.09	8.95	3.18	0.70	4.18	1.09	0.70	1.09
thymus, fetal, pool1	10043-101F7	28.47	24.21	3.64	14.96	5.40	1.45	7.79	1.66	2.08	2.49
thyroid carcinoma cell line:KHM-5M	10776-110G2	5.72	7.18	0.00	1.06	0.27	0.13	0.93	0.40	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	11.45	7.96	1.40	2.51	0.28	1.12	0.84	0.84	0.00	0.14
thyroid, adult, pool1	10028-101E1	27.90	9.70	2.24	6.44	0.65	1.40	2.80	0.65	0.00	0.28
thyroid, fetal, donor1	10060-101H6	45.35	6.59	4.22	2.90	3.16	1.85	1.05	1.32	0.79	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	80.07	12.32	12.32	0.00	12.32	9.24	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	78.61	11.86	2.79	0.70	11.16	2.56	0.00	0.93	0.00	1.40
tongue, fetal, donor1	10059-101H5	148.57	16.55	3.15	0.39	11.82	7.09	0.00	1.18	2.36	0.39
tonsil, adult, pool1	10047-101G2	36.66	10.12	6.71	9.92	4.11	2.40	4.01	0.90	0.40	0.60
trachea, adult, pool1	10029-101E2	18.65	4.83	2.54	3.11	1.55	1.23	1.47	1.15	0.57	0.16
trachea, fetal, donor1	10058-101H4	47.70	5.39	3.46	0.38	5.39	2.69	1.15	1.15	0.77	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	9.92	2.83	0.71	0.00	0.35	0.00	0.35	0.00	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	5.98	11.45	1.72	0.81	0.61	1.72	0.61	1.62	1.52	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	12.85	16.61	4.07	7.36	0.31	0.94	1.72	1.57	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	20.93	0.00	0.00	0.00	0.00	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.29	8.21	1.02	0.85	0.00	0.17	0.34	0.85	0.25	0.08
umbilical cord, fetal, donor1	10057-101H3	27.12	2.09	0.00	2.09	4.17	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	62.28	9.73	8.53	2.73	4.95	3.41	0.68	0.68	1.02	0.51
uterus, fetal, donor1	10055-101H1	21.50	2.05	5.63	0.51	1.02	1.02	1.02	0.51	1.54	0.51
vagina, adult	10204-103F6	26.49	3.88	1.94	3.88	1.29	3.23	1.94	1.94	0.00	0.00
vein, adult	10191-103E2	28.93	5.48	4.82	4.82	1.32	1.10	1.75	0.22	0.22	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.82	7.21	0.53	3.47	0.27	0.27	2.40	0.00	0.00	0.27

Property "Nearest transcripts" (as page type) with input value "NM_001102367.2:-33 ENST00000517362.5:-219 ENST00000428926.6:-226 AK022564:-226 AK091394:-229 ENST00000517518.5:-267 BX248782:-267 ENST00000523816.5:-278 BC065558:-278 ENST00000519019.5:-280 ENST00000518649.5:-292 ENST00000518868.5:-298 AK123532:-298 AK023200:-453" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.